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ABSTRACT 
Uruguay has the second highest breast cancer incidence rate in Latin America (Ferlay et 
al., 2013). Cervical cancer is the second leading cause of death in Uruguay (Rodríguez, Fazzino, 
& Larrosa, 2010). Despite these troubling statistics, an opportunity exists to improve the lives of 
women through early detection of both cancers. Yet, there is a dearth of information about 
factors influencing early cancer screening in Uruguay. Furthermore, research in this area is 
hampered because there is no survey to assess these factors among Uruguayan women. Thus, the 
field of cancer prevention is substantially hindered and cannot move forward without a valid 
measure. Information obtained through such a measure can help health professionals understand 
psychosocial barriers (e.g., lower breast cancer knowledge) preventing women from screening 
and develop targeted health education interventions that have the potential to save women’s 
lives. This study addresses this gap by using item response theory (IRT) to examine and refine 
the first Uruguayan breast and cervical cancer measure, the Cancer Health Literacy Measure-
Breast and Cervical Cancer-Uruguay (CLM-BCC). This measure assessed women’s cultural and 
conceptual knowledge, which is an area of health literacy that is understudied at this point in 
time. Cultural and conceptual knowledge is comprised of women’s attitudes, beliefs, emotions, 
and knowledge towards breast and cervical cancer. In 2011, data were collected using the CLM-
BCC by partnering with the Universidad Católica del Uruguay and the Comisión Honoraria de 
Lucha contra el Cáncer. Participants included 411 native Uruguayan women (≥ 40 years in 5 
regions across the country). By design, approximately 50% of women were up to date on their 
mammogram and Pap test screenings (within the past 2 years). CLM-BCC knowledge items 
examined in this study consisted of 22 items assessing women’s knowledge of breast and 
cervical cancer and screening. IRT, more specifically explanatory item response modeling and 
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Mokken scaling, are novel and uncommon approaches in health measurement making this one of 
the first public health studies to use these beneficial procedures. Findings revealed three Mokken 
scales for breast and cervical cancer knowledge items: (a) breast cancer self-detection, (b) breast 
cancer other detection, and (c) the cervical cancer knowledge scales. IRT analyses indicated that 
each scale item significantly contributed to the overall models and identified 7 unscalable items. 
Item parameter estimates were further refined for 2 out of 3 subscales by adding participant-
based characteristics (fixed effects) into the model, which also significantly contributed to each 
scale or helped explain or account for the differences in cancer knowledge. Women who 
obtained a mammogram in the last 2 years were 2.07 times likely to have more breast cancer 
self-detection knowledge compared to those who were not. Those who had obtained a Pap test in 
the past two years and resided in the city of Artigas (city in the province farthest from Uruguay's 
capital of Montevideo) had significantly higher cervical cancer knowledge scores. Women who 
were up to date for their Pap test were 2.26 times likely to have more cervical cancer knowledge 
when compared to those who had not. Similarly, Artigas residents were 2.21 times more likely to 
have more cervical cancer knowledge compared to women from other areas. 
  Overall, this study provided evidence that there is a direct link between screening status 
and knowledge levels for breast cancer self-detection and cervical cancer knowledge. These 
findings provide practical implications for developing knowledge based cancer promotion 
interventions. Using IRT helps researchers move the field of health measurement forward by 
providing an example of how to validate knowledge item scores on the first cultural and 
conceptual knowledge measurement instrument and articulate psychosocial processes 
influencing breast and cervical cancer screening. Thus, this study contributes to survey research 
by providing a tangible example of how IRT can be used in measurement development and how 
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EIRM surpasses traditional IRT (i.e., one and two parameter logistic regression) to provide more 
information for developing a concise, theoretically-driven, and psychometrically sound measure 
for clinical and health education settings. Study findings extend the field by bridging theory with 
advanced statistics. 
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CHAPTER 1 
INTRODUCTION 
Uruguay has the second highest breast cancer incidence rate in Latin America (Ferlay et 
al., 2013). Although highly prevalent, breast cancer can be reduced through regular screening 
such as mammograms (especially for women over the age of 40) and clinical breast exams 
(Ferlay, Héry, Autier, & Sankaranarayanan, 2010). Cervical cancer is a preventable disease 
(National Cancer Institute [NCI], 2012). Currently, cervical cancer is the second leading cause of 
death among women in Uruguay (Ferlay et al., 2013; Rodríguez, Fazzino, & Larrosa, 2010). 
Women’s risk for cancer increases as they age; therefore, we will witness an increase in breast 
and cervical cancer in the Americas due to the increase in longevity (Comisión Económica para 
América Latina y el Caribe [CEPAL], 2008; Lozano et al., 2013). Recent demographic data 
indicate that the burden of breast cancer will double, especially in areas with limited resources 
such as South America (Soerjomataram et al., 2012).  Despite these troubling statistics, an 
opportunity exists to improve the lives of women through early detection of both cancers. 
Therefore, there is an urgent need for research in Uruguay measuring determinants of breast and 
cervical cancer screening among the aging population. This study is a response to the Ministers 
of Health for the Americas’ (2007) call to assess inequities and develop appropriate solutions 
that “strengthen our understanding of the relationship between health determinants and their 
consequences” to prepare for the future (p. 20). 
Cancer screening in Uruguay 
Regular screenings are the most effective method of promoting early treatment and 
increasing chances of survival for breast and cervical cancer. Uruguay’s health system 
guarantees women ages 40-59 one day of paid leave every other year for women to obtain a 
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mammogram and Pap test (Ministerio de Salud Pública, 2009). Despite these free services, the 
breast cancer mortality rates in Uruguay are high which is likely to be due, in part, to 
underscreening. The current literature in Uruguay indicates low mammography and 
Papanicolaou (Pap) test screening rates for women (International Cancer Screening Network, 
2011; Reyes-Ortiz et al., 2007; Reyes-Ortiz, Velez, Camacho, Amador, Ottenbacher, & 
Markides, 2008). Differences in breast cancer screening rates by province have been found, 
which may be due to limited accessibility to screening or other factors such as education level, 
literacy levels, and age distribution (Cazap et al., 2008; International Cancer Screening Network, 
2011; Reyes-Ortiz et al., 2007; Reyes-Ortiz et al., 2008). At this time, there is a dearth of 
information about factors influencing early cancer screening in Uruguay (Bray et al., 2004; 
Reyes-Ortiz et al., 2007).  
Because the literature is sparse in this area, factors influencing screening behaviors 
among Uruguayan women are unknown. This study will use the United States’ (U.S.) cancer 
screening literature among Latinas as a framework for understanding screening disparities in 
Uruguay.  Health determinants affecting Latinas’ health in the U.S. may work similarly among 
Uruguayan women. However, it must be acknowledged that these two populations are distinct 
despite sharing a common language and similar cultural traits. Therefore, these groups do not 
comprise a homogenous group, yet because of their similarities some parallels can be drawn in 
the literature in terms of cancer screening behaviors.  
Current ongoing projects examining breast and cervical cancer in Latin America can 
inform us of cancer treatment at the population and genetic levels. For instance, the NCI project 
titled “Molecular Profiling of Stage II and III Breast Cancer in Latin American Women receiving 
Standard of Care Treatment” is a partnership with countries in the Americas (Uruguay, 
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Argentina, Brazil, Chile, and Mexico) to collect data that can be used to understand the effects of 
breast cancer therapies on Latin American women (NCI, 2014). This research is important and 
needed to further cancer treatment, however neither the NCI nor other global health agencies 
currently host projects that examine psychosocial factors influencing cancer screening among 
Latin American women. In fact, to date, there has been no research focused on psychosocial 
factors influencing breast and cervical cancer screening in Uruguay. Such information is 
imperative to promote early detection and reduce breast and cervical cancer mortality rates.  
Cancer and Health Literacy 
Health literacy provides an excellent framework to examine and understand psychosocial 
factors influencing breast and cervical cancer screening in Uruguay. The health literacy 
framework can be used to elucidate how cultural and structural processes may influence breast 
and cervical cancer screenings. Health literacy refers to an individual’s ability to obtain, process, 
and understand basic health information and services for making appropriate health decisions 
(Ratzan & Parker, 2000). Health literacy is composed of four components: print literacy, oral 
literacy, numeracy, and cultural and conceptual knowledge (Institute of Medicine [IOM], 2002) 
(Figure 1). 
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Figure 1. Health Literacy components (IOM, 2002) 
Several conceptual advances have been made in these areas. Yet, two specific elements of health 
literacy that have not received much attention in the field conceptually and measurement-wise 
are cultural and conceptual knowledge (Baker, 2006). Cultural knowledge refers to information 
and ideas obtained through life experiences and social processes. Investigating cultural and 
conceptual knowledge allows researchers to understand how culture influences women’s breast 
and cervical cancer screening behaviors (IOM, 2002). Conceptual knowledge is the learning and 
transmission of specific cultural knowledge into the larger concept of health (IOM, 2002). 
Individuals with higher cultural and conceptual knowledge are able to elaborate on systems, 
procedures, and information relating to health conditions and access the appropriate health 
services to improve their health. To effectively build health literacy among women, researchers 
must examine the interconnections between breast and cervical cancer and cultural and 
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conceptual knowledge to determine how women in Uruguay come to know, comprehend, and 
make decisions regarding breast and cervical cancer screenings (IOM, 2002).  
Cultural processes and cancer screening disparities 
Cultural processes play a key role in cancer screening disparities (Kagawa-Singer et al., 
2011). Culture consists of attitudes, beliefs, and values, which in turn shape an individual’s 
behavioral and emotional responses (Betancourt & López, 1993). Cultural processes provide a 
schema or cognitive framework for individuals to take in information about their health and 
determine possible options for diagnoses and treatments (IOM, 2002). Attitudes, beliefs, and 
emotions influence one’s definition of illness and health behaviors (Kleinman, 1980). For 
example, women may learn growing up that it is immodest to bear one’s chest to a man. A 
woman who knows this may perceive a clinical breast exam as inappropriate when performed by 
a male medical doctor. Recent research has emphasized the influence of cultural processes on 
cancer screening behaviors among underserved populations (Elder, Ayala, Parra-Medina, & 
Talavera, 1997; Flynn, Betancourt, & Ormseth, 2011; Kagawa-Singer et al., 2011). For instance, 
Flynn and colleagues (2011) found that screening emotions negatively affect Latinas’ clinical 
breast exam behavior. However, there are no extant cultural measures; therefore, more research 
focusing on developing and validating cultural measures is necessary to advance the fields of 
health literacy and cancer control.  
 Currently, there is a growing body of literature on social determinants and cultural 
processes influencing breast and cervical cancer screening, yet aspects of cultural and conceptual 
knowledge are not clearly defined or measured within this literature. For this study, cultural and 
conceptual knowledge will be operationalized as attitudes, beliefs, emotions, and knowledge 
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toward breast and cervical cancers and screening practices (Figure 2) (Buki & Quintero-Johnson, 
2009).  
 
Figure 2. Cultural and Conceptual Knowledge 
Attitude is a learned response towards an object (Fishbein & Azjen, 1975). Belief represents 
information that an individual has about an object that cannot be tested (Fishbein & Azjen, 
1975). Emotion is a short-term, biologically driven pattern of perception, experience, physiology, 
and communication in response to specific physical or social events (Campos, Keltner, & Tapias, 
2004). Knowledge refers to information or facts about a topic that can be tested or evaluated. 
This study will only examine the domain of knowledge concerning breast and cervical cancer 
and screening. 
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Current Health Literacy Measures 
Current health literacy measures (e.g., Test of Functional Health Literacy in Adults) have 
been developed specifically for the U.S. population. These measures focus on cognitive abilities 
such as numeracy and reading fluency, often overlooking the influence of cultural and 
conceptual knowledge on cancer screening (Baker, 2006). The current literature indicates that in 
the U.S., Latinas encounter unique barriers and facilitators to breast and cervical cancer 
screenings, yet little research has integrated these findings into the larger health literacy 
framework. At this point in time, the lack of health literacy measures drawing on cultural and 
conceptual knowledge and social determinants may lead researchers to make inaccurate 
conclusions about factors influencing breast and cervical cancer screening.  Furthermore, the 
field of health literacy measurement has faced criticism in the past few years for creating new 
measures that are not based on theory and that do not connect with the field of clinical and 
applied health work (Pleasant, McKinney, & Rikard, 2011). Pleasant and colleagues (2011) 
recommended that new health literacy measures be built on a testable theory and consist of latent 
multidimensional constructs that can be measured along a continuum. Furthermore, it has been 
recommended that health literacy assessment questions should have a range of difficulty levels 
and test well (IOM, 2009). This means that researchers should use measurement assessment 
methods that account for these aspects when developing and validating health literacy measures. 
Well-developed measures of cultural and conceptual knowledge are imperative for 
elucidating how cultural and conceptual knowledge influences Uruguayan women’s screening 
practices. The Cancer Health Literacy Measure-Breast and Cervical Cancer-Uruguay (CLM-
BCC) was developed to expand the field of health literacy (Buki, Yee, & Reich, 2011). 
Validating knowledge item scores on this new measure of cultural and conceptual knowledge 
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will help create a useful screening tool for health educators to use when developing interventions 
and for clinicians to assess patients’ health literacy. One methodology that will help further 
develop this area of health literacy and refine the CLM-BCC is item response theory (IRT), 
which is described in the next section. 
Item Response Theory 
For this study, IRT will be used to examine the item properties of the CLM-BCC. IRT is 
a more modern measurement approach often used for analyzing categorical outcomes to 
questions or items on a measurement instrument in education and psychology research 
(validating item scores). IRT provides a comprehensive methodology to examine item and 
participant responses. The measurement model assumes a continuous latent variable (knowledge) 
which is estimated by a person’s responses to survey items and the properties of those items 
(Embretson & Reise, 2000). The overall latent trait score is designated by theta (θ).  IRT is a 
generalized linear model meaning that outcomes are measured in terms of probabilities ranging 
from 0-1. Thus, the probability of a woman correctly choosing the item depends on the overall 
theta (i.e., the continuous knowledge latent variable) level (i.e., breast cancer knowledge) and the 
item’s location on a theta scale (commonly referred to in the measurement literature as 
“difficulty”).  
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Figure 3. Item Characteristic Curve for Breast Cancer Knowledge 
According to Figure 3, if a woman’s breast cancer knowledge (i.e., the theta score) is 
greater than the item’s difficulty, then the probability of a correct response will be greater than 
.50 (which is the threshold for item difficulty and skill level indicated in Figure 3), indicating a 
higher level of breast cancer knowledge. If the difficulty of the item is greater than breast cancer 
knowledge, then the probability of answering correctly will be less than .50, indicating a lower 
level of breast cancer knowledge. An item characteristic curve (ICC) is a visual graph that 
indicates the probability that an individual endorses a specific response category as a function of 
overall knowledge that falls between zero and one (Stochl, Jones & Croudace, 2012). In an ICC, 
the level of the latent trait increases as the probability of an individual endorsing a correct 
response to an item increases (Hambleton, Swathinathan, & Rogers, 1991). The b parameter for 
an item is the point on the knowledge scale where the probability of a correct response is 0.5, 
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which indicates the item location position on the ICC or along the horizontal axis. The greater 
the value of the b parameter, the greater the knowledge level is needed for an examinee to have a 
50% chance of choosing the correct answer, making it a more difficult item. Easier items are 
located to the right or the higher end of the knowledge scale and more difficult items are located 
to the left lower end of the knowledge scale.  
Mokken scale analysis 
Mokken Scale Analysis (MSA) is an IRT method utilized to assess the dimensionality of 
a set of items. This scaling approach uses a Guttman or hierarchical scale that accumulates 
participants’ positive responses from easy to more difficult items that measure a unidimensional 
variable (van Schuur, 2003). MSA provides a useful starting point for scale construction because 
it does not impose severe restrictions on the functional form of item trace lines or ICCs 
(Gillespie, Tenvergert, & Kingma, 1987). Guttman scaling is sometimes known as cumulative 
scaling or hierarchical scaling, which establishes a unidimensional latent variable continuum for 
a scale (Weller & Romney, 1990). This means that all scale items measure a single latent 
variable (theta) and when a respondent correctly answers the 8
th
 item on a measure she will have 
correctly answered to the previous seven measure items. MSA scaling programs consists of two 
parts: an automated algorithm that partitions ordinal and dichotomous variables into scales and 
methods to investigate the assumptions of non-parametric models (van der Ark, 2007). MSA is a 
non-parametric IRT model. The MSA model checks the assumptions of non-parametric IRT 
models: unidimensionality, local independence, latent monotonicity, and non-intersection. This 
aspect is useful also for parametric IRT models because most of the assumptions are similar 
(unidimensionality, latent monotonicity, and local independence) for all popular parametric IRT 
models (e.g., one parameter logistic regression [1PL] and two parameter logistic regression 
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[2PL]). MSA also determines items that are unscalable or poor fitting items that can be removed 
from the scale. This procedure will help refine CLM-BCC knowledge items and further ground 
explanatory item response modeling (EIRM) analyses, as follows. 
Explanatory item response modeling (EIRM) 
Explanatory item response modeling (EIRM) is an innovative item response modeling 
technique developed in educational and psychological testing to provide in-depth information on 
personal characteristics and testing situations. This is a special case of generalized non-linear 
mixed modeling because the latent variable (theta) is interpreted as a random intercept as well as 
participants’ personal properties. Predictor (covariate) variables can be added into the model as 
fixed or random effects to predict the likelihood of an individual selecting a specific answer 
given personal characteristics of scoring higher or lower on a scale. By adding these covariates 
into the measurement model, measurement error does not increase which would occur if 
measuring theta and the covariates in a separate regression models. Including participant 
characteristics acknowledges and tests for factors specific to individuals that may influence 
breast and cervical cancer knowledge (Rutkowski et al., 2009). The inclusion of covariates in 
item response models can be seen as a way to account for model misfit, allowing for a richer 
analysis of the data and providing more detailed information about the relationships among 
participant characteristics and response means (Junker, 1999; Rupp, 2002). Adding person 
covariates improves model fit because it relaxes an assumption of the IRT model that mean 
knowledge is constant and normally distributed for the entire population. It can also be used to 
improve item parameter estimation modestly and can lead to higher accuracy in the estimation of 
person knowledge parameters (Adams, Wilson, & Wu, 1997). This also helps account for 
systematic differences in theta. This technique combines the strengths of IRT and new advances 
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in the field of multilevel modeling to provide a more targeted and informed analysis. A two 
parameter logistic (2PL) regression explanatory item response model is the type of EIRM 
employed in this study, which is a doubly explanatory model meaning that it is explanatory in 
terms of knowledge for both personal characteristics and items (De Boeck & Wilson, 2004).  
Analyses 
For this study, Mokken scaling was used first to determine the dimensionality (or latent 
structure) and scalability of items. Subsequently, traditional item response modeling was used to 
obtain item specific parameters. Explanatory item response modeling was performed next where 
person covariates were added into the item response models to determine how item specific 
parameters change when adding in predictors for theta (or the latent variable).  
Research Hypotheses 
By applying MSA and EIRM to CLM-BCC knowledge items (Buki, Yee, & Reich, 
2011), the following four hypotheses will be examined in this study: 
Hypothesis 1: There may be unscalable items in the CLM-BCC. 
Hypothesis 2: Mokken scale analysis will determine a set of scalable items that measures 
a unidimensional latent variable. 
 Hypothesis 3: After the removal of unscalable items, the CLM-BCC will consist of two 
unidimensional subscales: (a) breast cancer knowledge and (b) cervical cancer knowledge.  
Hypothesis 4: IRT and EIRM will determine if women’s breast and cervical cancer 
knowledge item responses are influenced by participant characteristics, specifically being up to 
date for cancer screenings, cancer education, province, family cancer history, age, and having 
had children. 
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Specific Aims of the Study 
This study will focus on exploring and refining the psychometric properties of one of the 
first measurements of cultural and conceptual knowledge, the CLM-BCC. The specific aims of 
this study are the following:  
1. To determine if there are any unscalable CLM-BCC knowledge item(s). 
2. To confirm unidimensionality of CLM-BCC knowledge subscales. 
3. To test and explain breast and cervical cancer knowledge item responses and 
their relationship to participants’ characteristics. 
4. Develop a concise and psychometrically sound measurement for cultural and 
conceptual knowledge to be used in clinical and health education settings, and 
to build theory. 
5. Demonstrate the benefit of using innovative IRT measurement approaches such 
as EIRM and MSA to validate and refine scale items. 
Significance of the Study 
Women in Uruguay have high breast and cervical cancer mortality rates, yet little is 
known about factors influencing screening. Furthermore, current health literacy measures do not 
account for the influence of health determinants and cultural processes on screening, nor do they 
measure cultural and conceptual knowledge. The CLM-BCC is the first health literacy scale to 
measure cultural and conceptual knowledge and one of the first measures used in Uruguay to 
examine disparities in women’s breast and cervical cancer screening behaviors.  
No studies to date have examined the psychometric properties of the CLM-BCC. MSA is 
an IRT methodology that allows us to examine and refine measures. EIRM allows us to examine 
the influence of personal and item characteristics on participants’ breast and cervical cancer 
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knowledge more precisely than standard IRT methods. Currently, these IRT methodological 
approaches (EIRM and MSA) are valuable techniques, especially for psychometric development, 
that have not been fully explored in the field of public health. This study will document the 
significant contribution of these methodologies for measurement development in the field of 
community health and benefit health promotion research and assessment. The completion of this 
study will: 
1. Ascertain the reliability and validity of CLM-BCC item scores for this present 
sample. 
2. Refine the CLM-BCC for use in clinical and targeted intervention settings to 
understand how knowledge influences screening behaviors among Uruguayan 
women. 
3. Apply a more precise measurement method to determine barriers and 
facilitators to breast and cervical cancer screening among Uruguayan women. 
4. Provide a good example of how advanced IRT methodologies such as EIRM 
and MSA can be applied to community health research and assessment. These 
findings will help further develop the fields of psychometrics and health 
promotion. Findings will provide detailed information on the target 
population’s breast and cervical cancer knowledge.  
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CHAPTER 2 
REVIEW OF THE LITERATURE 
Overview 
 This chapter reviews the theoretical and empirical studies that will guide the design of 
this project and inform data analyses. First, the chapter begins with a brief description of 
women’s health and social inequalities, and current demographic trends. This is followed by 
breast and cervical cancer incidence, mortality, and risk factors in South America and 
specifically Uruguay. Subsequently, risk factors influencing breast and cervical cancer screening 
are examined followed by brief descriptions of the health system and factors influencing health 
in Uruguay. An overview of factors influencing breast and cervical cancer knowledge among 
Latinas in the U.S. is given and the health literacy framework will be explored as a way to 
inform and elucidate underlying factors influencing breast and cervical cancer screening among 
Uruguayan women. Pertinent aspects of health literacy, specifically cultural and conceptual 
knowledge, are explored. The specific domain of knowledge that shapes and informs women’s 
understanding of cancer control is presented. An overview of knowledge measures and response 
options used in the literature is presented and the limitations of current health literacy measures 
are discussed. Lastly, an appropriate methodology for validating CLM-BCC item scores and 
examining the influence of Uruguayan women’s personal characteristics’ on knowledge are 
discussed.  
Women’s Health and Social Inequalities 
Our health is shaped largely by our context (Committee on Social Determinants of Health 
[CSDH], 2008; Marmot, 2005). Health determinants are contextual factors that influence health 
outcomes and disease prevention, creating situations of inequity among countries and even 
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within a single country. As community health researchers, our goal is to improve an individual's 
quality of life. Therefore, it is our duty to document and understand health determinants and their 
influence on health outcomes and disease prevention; with this information, we can improve the 
population's health and promote health equity (CSDH, 2008; Marmot, 2005).  
The United Nations (UN) recognizes the influence of health determinants and has 
developed the UN’s Millennium Development Goals (MDGs) to improve the quality of life for 
disadvantaged populations. Two of the eight MDGs target improving quality of life and health 
care for females (MDG 3: Promote gender equality and empower women, and MDG 5: Improve 
maternal health; UN Millennium Project, 2005). Women still experience systematic 
discrimination and exclusion due to unique risk factors such as limited access to health care, 
lower levels of formal education, and limited occupational opportunities (UN Millennium 
Project, 2005). These factors compel us to consider women’s health a pressing issue in today’s 
society, as they increase women’s risk for disease and premature death (UN Millennium Project, 
2005).  
For instance, one area in which these factors appear to influence women’s health 
outcomes is breast and cervical cancer control (i.e., prevention and treatment; Forouzanfer et al., 
2011; World Health Organization [WHO], 2011). After skin cancer, breast cancer is the most 
common cancer worldwide among developed and developing countries, resulting in the main 
cause of all deaths for women globally (Ferlay et al., 2010). Cervical cancer is the third most 
common cancer in women worldwide (Ferlay et al., 2010). Breast and cervical cancers account 
for a major component of the 2008 disability adjusted life year rates (DALY) for women 
globally (Soerjomataram et al., 2012). The DALY is a population-level metric indicating how the 
burden of disease reduces years of living, meaning that one DALY represents the loss of one 
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year of health due to breast and cervical cancer (WHO, 2015). In Latin America and the 
Caribbean, DALY rates for breast and cervical cancer counts are quite high (411 per 100,000 for 
breast; 355 per 100,000 for cervical; Soerjomataram et al., 2012). This study will focus on breast 
and cervical cancer in Uruguay. Estimates from this country indicate that Uruguayan women 
have some of the highest breast and cervical cancer incidence rates in the Americas (Ferlay et al., 
2010).  
Current Demographic Trends 
Current demographic trends indicate that we will likely observe an increase in the 
number of older women being diagnosed with cancer (United Nations Statistics Division, 2015). 
The median age of breast cancer diagnosis for Uruguayan women is 61.0 years (Krygier et al., 
2007). The proportion of older adults (aged 60 and older) in Latin America will increase at a rate 
three times faster than the growth rate for the general population between 2000-2050 and six 
times higher for the years 2025-2050 (CEPAL, 2008). Projections estimate that the population 
will rise from 677 million in 2025 to 763 million in 2050 (CEPAL, 2008). The population of 
older adults comprises 21.4% of Uruguay’s population and is continuing to grow. Furthermore, 
the average life expectancy has increased globally in the last decade making non-communicable 
diseases (i.e., cancer) one of the primary causes of death among adults 40 years and older 
(Lozano et al., 2013). This information is troubling given the fact that this growing adult 
population has greater needs than the extant resources and systems in Latin America can handle 
(CEPAL, 2008; Jackson et al., 2009) and the burden of breast cancer will likely double in areas 
such as South America (Soerjomataram et al., 2012). Therefore, research focusing on the 
determinants of breast and cervical cancer screening in Uruguay among this population is timely 
and essential. 
18 
 
Breast Cancer in South America 
Breast cancer is a growing concern in South America. Currently, South American breast 
cancer mortality rates are comparable to more developed regions of the world (14.9 per every 
100,000 women; Ferlay et al., 2013). According to the GLOBOCAN 2012 version 1.0 database 
South American mortality rates (14.0 per every 100,000 women) tend to be higher than 
developing Latin American countries such as Mexico (9.7 per every 100,000 women). South 
American countries with considerable economic stability and developed countries have some of 
the highest rates of breast cancer incidence and mortality. Screening plays an important role in 
cancer control because later detection leads to more serious prognoses with limited treatment 
options. Within the continent, Uruguay (90.7 per every 100,000) and Argentina (74.0 per every 
100,000) have the highest incidence rates for this region (Bray et al., 2004; Ferlay et al., 2010b).  
Comparisons of South American countries’ mortality rates should be interpreted with 
caution because cause-specific mortality death rates are biased for most developing countries. In 
South America only 25% of deaths are recorded by vital registration systems and in the poorest 
countries much less, 5-10% (Lopez, Ahmad, Guillot, Inoue, & Ferguson, 2001; Mathers, Fat, 
Inoue, Rao, & Lopez, 2005). Uruguay has a unique history of collecting annual mortality 
statistics since 1879, and cause-specific mortality data since 1885 (Birn, 2005). In 2009, 
Uruguay’s vital registration system covered 95% of deaths in the country and 17% of deaths 
reported had ill-defined causes of mortality. The WHO considers Argentina’s vital registration 
system to be incomplete and it cannot be used to calculate the global burden of disease because 
the proportion of ill-defined classification codes is greater than the percentage of the data 
completeness (WHO, 2014; WHO, 2012).  
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The high breast and cervical cancer incidence in South America is often attributed to an 
increase in risk factors related to Westernization (i.e., diet, increased sedentary activity, and 
increases in the national average age of parity; Alvaro & De Stéfani, 2012). Furthermore, high 
breast and cervical mortality rates are attributed to more women being screened at advanced 
stages of cancer (stages III and IV) (Alvaro & De Stéfani, 2012). As these current trends 
continue in South America, there will be a disproportionate increase in cancer mortality due to 
the fast growing aging population (Jackson, Strauss, & Howe, 2009).  
Breast cancer in Uruguay  
Breast cancer is the leading cause of cancer death among women in Uruguay. Currently, 
71 per every 100,000 women have breast cancer in Uruguay (CHLCC National Cancer Registry, 
2010). Uruguay’s breast cancer mortality rate based on the GLOBOCAN database (22.7 per 
every 100,000 women) is much higher than rates for most upper-middle and high-income 
countries such as the U.S. (14.9 per every 100,000 women; Ferlay et al., 2013). One explanation 
for this striking difference in mortality rates is that fewer older women in Uruguay are obtaining 
mammograms regularly in comparison to women in the U.S. Data appear to bear this out. 
According to Reyes-Ortiz and colleagues (2007), 24.1% of women aged 60 and older from 
Montevideo in the SABE Study 1999-2000 (Albala et al., 2005; Peláez et al., 2003) reported 
obtaining a mammogram, a much smaller percentage than that reported for U.S. Hispanic women 
aged 30 and older in the 2000 National Health Interview Survey (68.2%) (Swan et al., 2003) and 
for U.S. border Hispanics in the 2000 Behavioral Risk Factors Surveillance System (59.2%) 
(Coughlin et al., 2003). However, the differences across groups must be interpreted with caution 
given the different age ranges for screening in each study. 
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Table 1. Distribution of New Breast Cancer Cases from 2002-2006 by Province in Uruguay  
 Breast Cancer Cases 
Province 
Number of 
Cases 
Population of 
Women per 
Province in 2004 
New Cases per 
Province (%) 
Artigas 126 38,937 58.3 
Flores 55 12,713 61.9 
Maldonado 307 71,087 63.4 
Trienta y tres 105 24,282 61.7 
Montevideo 4803 707,750 85.1 
      Data taken from CHLCC (2010) 
Currently, there are no breast cancer incidence or prevalence rates available at the 
department level. Evidence indicates that the distribution of new breast cancer cases varies 
across the 19 provinces in Uruguay. According to Table 1, Montevideo has the highest 
percentage of new breast cancer cases (85.1%) compared to the other 4 provinces where data 
were collected for this study when using data from 2002-2006 (CHLCC, 2010). Variability in 
department cancer case distribution may indicate specific screening barriers and facilitators 
within Uruguayan residents’ communities.  
Risk factors 
There are two primary risk factors for breast cancer: gender and age (Hulka & Moorman, 
2001). Statistics indicate that females are more likely to develop breast cancer than males (Hulka 
& Moorman, 2001). Additionally, older women have a greater risk of developing the disease 
than younger women (McPherson, Steel, & Dixon, 2000). Further, research indicates that the 
higher a woman’s lifetime exposure to estrogen hormones, the greater her risk is for breast 
cancer. Some factors associated with greater estrogen exposure are nulliparity, early menarche, 
late menopause, prolonged exposure to estrogen replacement therapy after menopause, and 
having first live birth at a later age (Hulka & Moorman, 2001). Other risk factors include being 
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obese or overweight after menopause, recent use of oral contraceptives, family history of breast 
cancer, or having dense breast tissue (Hulka & Moorman, 2001; McPherson et al., 2000). 
Symptoms 
Furthermore, it can be speculated that because breast cancer can be asymptomatic, some 
women may delay screening if they do not have symptoms. Some individuals do display various 
symptoms of breast cancer in earlier stages. Symptoms of breast cancer are a breast lump or 
thickening of tissue that feels different from other tissue, bloody discharge from the nipple, 
change in breast shape or size, changes to skin over the breast, an inverted nipple, peeling, 
flaking or scaling of the nipple or breast skin, and redness or pitting of the skin over the breast 
(Osteen, 2001).  
Types of screenings 
There are three types of breast cancer screening exams used for early detection of breast 
cancer: breast self-exam, clinical breast exam, and mammogram. The breast self-exam (BSE) is 
short procedure where a woman checks her breast regularly for lumps. A clinical breast exam 
(CBE) is a physical examination of the breast done by a health professional to detect palpable 
tumors or abnormalities (Saslow et al., 2004). A CBE is not the most reliable method of 
screening because some doctors may not perform this procedure routinely on patients or patients 
may be reluctant to request the procedure (Saslow et al., 2004). Mammography is the most 
effective screening tool for breast cancer. It consists of a low-dose x-ray procedure used to detect 
cancer at a stage when treatment may be more effective. The Global Breast Health Initiative 
(GBHI) recommends that countries perform mammography screening on women ages 50-65 
biannually (Yip et al., 2008). Once this age group is regularly screened mammograms should be 
provided to women ages 40-49 every 12-18 months and biannually to women ages 65 and over 
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(Yip et al., 2008). Despite the widespread use of mammography screening, there still are some 
populations today who are unable to obtain regular screenings (Yip et al., 2008). 
Breast cancer screening 
There is little information on breast cancer screening policies and screening rates in 
South America. Oftentimes screening policies depend upon the governmental agenda, budget, 
and infrastructure. Furthermore, extant research suggests that most breast cancer screening 
policies and programs in Latin America are not supported by research despite the growing 
incidence and mortality rates (International Cancer Screening Network [ICSN], 2011; Robles & 
Galanis, 2002). The only mammogram screening rate information including Uruguayan older 
adults available comes from a 7 country study from SABE 1999-2000 (Albala et al., 2005; 
Peláez et al., 2003). In this study, only 24.1% of female participants ages 60 or older in 
Montevideo, Uruguay and 23.4 % in Buenos Aires, Argentina reported obtaining a mammogram 
in the past two years (Reyes-Ortiz et al., 2007). The lack of public information on national 
screening rates makes it difficult to know how many women are being screened and what 
initiatives that can be implemented to improve screening rates. 
At this time little information exists on screening rates. The current extant literature 
indicates that women in Uruguay are obtaining screenings at lower rates than Latinas in the U.S. 
(a population who is considered to have lower screening rates when compared to their White 
non-Hispanic counterparts). Therefore, it is imperative to explore factors influencing 
mammography screening in Uruguay. Early detection of breast cancer with regular screenings is 
one of the most effective methods of promoting early treatment and increasing chances of 
survival (Flórez et al., 2009). Currently, mammography screening is the recommended routine 
procedure for women over the ages of 40 to detect breast cancer. The earliest sign of breast 
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cancer is often detected as an abnormality through a mammogram before it can be felt by the 
woman or a health care professional (American Cancer Society, 2015).  
Cervical Cancer in South America 
More than 85% of the burden for cervical cancer occurs in developing areas such as Latin 
America and Africa, accounting for 13% of all female cancers worldwide (Ferlay et al., 2010). 
Incidence and mortality rates vary within this region primarily by income level (Ferlay et al., 
2010). According to the GLOBOCAN database in South America, 20.3 per every 100,000 of 
women were diagnosed with cervical cancer which is much higher than developed countries (9.9 
per every 100,000; Ferlay et al., 2013). Mortality rates for South America (8.6 per every 100,000 
women) are higher than more developed countries as well (3.3 per every 100,000; Ferlay et al., 
2013).  
Cervical cancer in Uruguay 
Cervical cancer is the second leading cause of death in Uruguay (Rodríguez, Fazzino, & 
Larrosa, 2010). It ranks third in incidence after breast and colon cancer (Rodríguez, Fazzino, & 
Larrosa, 2010). There are 320 new cases and 140 deaths per year in Uruguay due to cervical 
cancer (Rodríguez et al., 2010). In 2012, according to the GLOBOCAN database, Uruguay had a 
cervical cancer incidence rate of 18.9 per 100,000 women and a mortality rate of 7.1 per 100,000 
women (Ferlay et al., 2013). These rates are low when compared to other South American 
countries, yet they are higher than those of most developed upper middle-income countries such 
as the U.S. In the U.S., the cervical cancer incidence rate was 6.6 per 100,000 women, and 
mortality rate was 2.7 per every 100,000 women in 2012 (Ferlay et al., 2013). Currently, there 
are no incidence and prevalence rates available at the Uruguayan province level for cervical 
cancer. Within Uruguay, the distribution of new cervical cancer cases vary by province; Treinta 
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y tres has the highest percent of new cases (26.2 %) followed by Artigas (19.6 %; see Table 2) 
(CHLCC, 2010). 
Table 2. Distribution of New Cervical Cancer Cases from 2002-2006 by Province in Uruguay  
 Cervical Cancer Cases 
Province 
Number of 
New Cases 
Population of 
Women by 
Province in 
2004 
Distribution of 
New Cases by 
Province (%) 
Artigas 43 38,937 19.6 
Flores 15 12,713 18.8 
Maldonado 66 71,087 16.6 
Treinta y tres 41 24,282 26.2 
Montevideo 830 707,750 18.8 
           Data taken from CHLCC (2010) 
Cervical cancer screening rates 
 Uruguay started its first state-wide cervical cancer screening program in 1994 providing 
Pap tests to women ages 30-70 every 3 years (Dowling, Klabunde, Patnick, & Ballard-Barbash, 
2010). The program is still in existence today, yet the most recent participation rates from 2007-
2008 were quite low, indicating that only 10% of the population participated in the program 
(ICSN, 2011). Prior Pap test screening literature suggests that Uruguay has a history of low 
screening rates. Data from 1999-2000 SABE indicates that 23.7% of women 60 years and older 
from Montevideo reported obtaining a Pap test in the past two years (Reyes-Ortiz, Velez, 
Camacho, Ottenbacher, & Markides, 2008), which is much lower than underscreened U.S. 
Hispanics 65 and older (47.4%; Coughlin & Uhler, 2000). Data from the 2008 WHO World 
Health Statistics indicates that 62% of Uruguayan women obtained a Pap test from 2000-2006 
despite the recommendations by El Ministerio de Salud Pública (The Ministry of Public Health, 
n.d.) that every woman receive a Pap test every 2 years.  
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Detection and symptoms of cervical cancer 
Although cervical cancer is one of the most preventable forms of cancer, it is often not 
detected until much later stages of cancer. One possible explanation is that cervical cancer is a 
slow-growing cancer, which may result in women not experiencing symptoms until advanced 
stages of the disease (NCI, 2012). Most women experience symptoms when the cancer grows 
larger (NCI, 2012). Symptoms of cervical cancer include persistent or chronic HPV infection; 
vaginal bleeding after intercourse, in between periods, or after menopause; having watery, 
bloody vaginal discharge that may be heavy or have a foul odor; pelvic pain; or pain during 
intercourse (Rodríguez, Fazzino, & Larrosa, 2010) . 
Risk factors 
The Human Papilloma Virus (HPV) is the main cause of most cervical cancers today. It is 
a very common virus with over 100 strains, yet 6 types account for 85% of cervical cancers 
worldwide (NCI, 2012). Two of these HPV strains, 16 and 18, account for 70% of cervical 
cancer cases. In Central and South America, HPV 16 and 18 account for 65% of all cervical 
cancer cases (Muñoz, 2004). HPV is transmitted through skin to skin contact with the body of an 
individual infected with HPV. Cervical cancer is most common among women in their 40’s and 
50’s. Having a persistent or chronic infection with a high risk HPV strain is the leading risk 
factor for developing cervical cancer (Almonte et al., 2008). Other risk factors that have been 
identified in the literature are smoking, giving birth to multiple children, using birth control pills 
for five or more years, or immunosuppression (Almonte et al., 2008). Having multiple sexual 
partners, Chlamydia infection, diets low in fruits and vegetables, being overweight, being 
younger than 17 years old when having a first full term pregnancy, and a family history of 
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cervical cancer have also been identified as risk factors (Almonte et al., 2008). These factors, 
when coupled with HPV, can increase a woman’s risk of developing cervical cancer. 
Cervical cancer prevention and screening 
 Cervical cancer risk can be reduced by obtaining regular cervical cancer screenings, Pap 
test (or cytology). During a Pap test, a healthcare provider takes a sample of tissue from the 
cervix to identify cell changes in the cervical tissue. However, abnormal cell changes are not 
always an indicator of cervical cancer. The WHO (2006) recommends women obtain a Pap test 
every three years from ages 25-65. 
 Pap testing was introduced to Latin America and the Caribbean in the 1960’s, yet in most 
countries today Pap testing programs are nonexistent or have largely failed (Herrero et al., 2008; 
Murrillo et al., 2008). Various studies have found that Latin American cervical cancer screening 
programs lack the appropriate infrastructure for evaluation to ensure quality and uniformity for 
screening and follow up with positive diagnoses (Arrossi, Sankaranrayanan, & Parkin, 2003; 
Muñoz et al., 2008; Murrillo et al., 2008). This compromises these programs’ quality and reach. 
At this time it is unclear whether the programs have effectively reduced Latin American cervical 
cancer mortality rates (Muñoz et al., 2008).  
 The HPV vaccine is especially effective at reducing cervical cancer risk if given before 
acquiring an HPV infection (Koutsky et al., 2002). The series of vaccines are usually given 
before an individual’s first sexual intercourse. Yet, the vaccine does not prevent all HPV 
infections; it prevents only two specific strains (16 and 18). Therefore, women must continue 
obtaining a regular Pap tests despite being vaccinated (Harper et al., 2004). 
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Individual characteristics influencing cancer knowledge 
Because there is little information about factors influencing cancer knowledge in 
Uruguay, this section will include research based on Latino samples in the U.S. Individual 
characteristics such as age and cancer education have been identified as factors influencing 
cancer screening (Buki, Jamison, Anderson, & Cuadra,, 2007; Otero-Sabogal, Stewart, Sabogal, 
Brown, & Pérez-Stable, 2003). These characteristics may also influence breast and cervical 
cancer knowledge. The extant screening literature primarily focuses on examining the influence 
of individual characteristics and knowledge (predictors) on breast and cervical cancer screening 
behaviors (screening outcomes). Few researchers have taken explanatory approaches in a 
measurement context to examine the influence of individual characteristics on breast and cervical 
cancer knowledge which can be beneficial for survey and intervention development. Therefore, it 
is important to consider how individual characteristics may influence participants’ knowledge 
levels.  
Geographic location 
The resources and assets, or lack thereof, within a community serve as health 
determinants that shape women’s cancer knowledge (Buki, Montoya, & Linares, 2013). 
Geographic location often determines access to educational programs, screening exams, and 
information and services (Bigby, 2007). Women living in rural or remote locations may 
encounter obstacles such as limited transportation, accessibility to health centers, and health 
information which may influence screening rates and knowledge when compared to urban 
settings (Calle, Flanders, Thun, & Martin, 1993; Casey, Thiede, & Klingner, 2001; Ogedegbe et 
al., 2005; O'Connor & Perrault, 1995). According to the 2011 Uruguayan Census (Instituto 
Nacional de Estadística, 2011), the provinces of Flores (13%) have the highest proportion of 
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citizens living in rural areas, followed by Treinta y tres (11%), Artigas (8%), Maldonado (3%), 
and Montevideo (1%). The literature also indicates that women often receive different medical 
care based on where they live and the health facilities providing care. For instance, in 
economically disadvantaged areas, women not only have poor access to health care-related 
resources, but also to education and employment opportunities (Bigby, 2007).  
 Cancer education 
Latina women typically acquire knowledge about breast and cervical cancer through an 
informal social context (e.g., friends and family) and formal programming (e.g., schools and 
health care settings) (Buki et al., 2004; Buki et al., 2007). In the literature, there is a positive 
relation between cancer education and breast cancer screening (Hansen et al., 2005; Nuño, 
Martinez, Harris, & Garcia, 2010). Yet, there are mixed findings in the literature focusing on 
cancer education and cervical cancer knowledge. A community-based study among Hispanic 
women indicated that women with lower acculturation levels had less cervical cancer knowledge 
and were less likely to obtain a Pap test (Harmon, Castro, & Coe, 2008). Another study among 
Hispanic women found different results. Findings indicated that women were half as likely to 
know the purpose of a Pap test (Lindau et al., 2002). These findings were also found among 
Hispanic women in a breast and cervical cancer screening promotion program. Women who 
participated in the program did not report increasing their Pap test knowledge, yet they did 
increase their Pap test uptake (Fernandez et al., 2009).  
Age 
Because women’s risk for cancer increases as they age, it is important to examine this 
association further in the literature. Hispanic women who are older are less likely to obtain 
regular breast and cervical cancer screenings, and generally have less cancer knowledge when 
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compared to younger women (Mandelblatt et al., 1999; Suarez, Roche, Nichols, & Simpson, et 
al., 1997). A cross-sectional survey among Hispanic women indicated that knowledge of breast 
and cervical cancer was significantly related to age in this study, meaning that older women 
knew less (Ramirez et al., 2000).  
Family history of cancer 
Research indicates that family history of cancer has a strong influence on screening 
behavior and can influence some aspects of knowledge (Bird et al., 2010; Buki, Montoya, & 
Linares, 2013; Mobley et al., 2009; Shah et al., 2007).  Findings from a cross-sectional study on 
Latinas along the U.S.-Mexico border indicated that women with and without a family history of 
cancer shared similar breast cancer knowledge levels (Bird et al., 2010). Yet, significantly more 
women with a family history of breast cancer correctly responded to the item, “Women should 
obtain breast ultrasounds and mammograms when receiving a clinical breast exam,” when 
compared to those without a family history (Bird et al., 2010). 
 Having children 
 For most women, the postnatal visit and sometimes first trimester prenatal visit include a 
Pap test which provides an excellent opportunity for clinicians to educate patients on regular Pap 
screening (Londo, Bjelland, Girod, & Glasser, 1994). Therefore, pregnancy or having children 
can be used as a predictor of regular Pap testing and may possibly influence women’s 
perceptions of cancer control (Buki et al., 2007).  
Factors influencing health in Uruguay 
To understand cancer control in Uruguay, it is imperative to first provide an overview of 
the country and the national health system. This section provides a brief overview of the extant 
health system, government health initiatives, and health concerns. Uruguay is an upper middle-
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income country in South America bordered by Brazil and Argentina. The capital of Uruguay, 
Montevideo, holds a seaport and borders the confluence of the Atlantic Ocean and the Río de la 
Plata. The country is inhabited by 3 million people and contains urban cities and rural farming 
communities (WHO, 2009). The country’s main industries lie in agricultural products and goods 
such as meat packing and tanning of leather goods (Central Intelligence Agency [CIA], 2013b). 
A majority of the country is high school educated (CIA, 2013). Also, a majority of the 
population is literate (97.8%; CIA, 2013b). Overall, Uruguay’s economy is strong and continues 
to grow. These factors help produce population health outcomes similar to developed countries. 
Health in Uruguay   
 Former President Tabaré Ramón Vázquez Rosas (2005-2010) was an oncologist who 
worked to improve education and working conditions during his presidency. Dr. Rosas is well 
known for his work in reducing tobacco consumption throughout the country, which now has 
some of the most stringent tobacco policies in the world. Overall, Uruguay has health that is 
comparable to most upper middle income countries. The average life expectancy at birth is 73.6 
years for males and 80.5 years for females (UN Statistics Division, 2015). The total expenditure 
on health per a capita is $979 (USD) or 7.4% of the Gross Domestic Product ([GDP]; The World 
Bank, 2013).  The country has a low infant mortality rate (9 per 1,000 live births) and a low 
under five years of age mortality rate (11 per 1,000 live births) (UNICEF, 2013). There are 
approximately 37 physicians per every 10,000 inhabitants in Uruguay (CIA, 2013b). Currently, 
97.8 % of total population has access to clean drinking water services (CIA, 2013b).  
Uruguay’s health system 
El Ministerio de Salud Pública (The Ministry of Public Health) sets the country’s 
standards for health and regulates the health sector. In December 2007, the country went through 
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health insurance reform to guarantee universal healthcare access and coverage to all individuals 
regardless of their ability to pay. Currently the health system is comprised of the private and 
public sectors. The private health care system consists of non-profit health care institutions 
(Mutualistas or Cooperativas) (Borgia, 2010). The public sector is run through the State Health 
Services Administration (ASSE) and other related agencies (Borgia, 2010). Public health 
insurance is provided for all Uruguayan citizens and residents who pay a certain percentage of 
their income into the Fondo Nacional de Salud (FONASA) (Borgia, 2010). This fund was 
created in 2007 as part of the healthcare equity reform. Each individual contributes into the 
FONASA or a separate health care fund based upon her income level bracket. FONASA works 
similarly to Social Security Insurance (SSI) in the U.S., as it is a collaborative fund where fees 
are deducted from regular pay. Unlike SSI, individuals can choose to have their deductions go 
towards FONASA or select Mutualistas. Health insurance is run by JUNASA, a sector of the 
ministry of health.  
 Public health initiatives 
The Ministry of Public Health has a health initiative focusing on cancer control 
(CHLCC).  The CHLCC has several active health campaigns and initiatives focusing on breast 
and cervical cancer. Their initiatives focus on positive health promotion campaigns directed at 
improving an individual’s quality of life and empowerment, termed as “Viva Mejor” (Live 
Better). CHLCC has several active media campaigns using television, radio, print, and posters to 
communicate their messages. The CHLCC also has an ongoing early breast and cervical cancer 
detection programs partnering with community organizations to inform and emphasize the 
importance of cancer control (CHLCC, 2012). This early detection program focuses on health 
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promotion by providing breast cancer screenings, supplying mammography machines to local 
clinics, and funding health centers to use mammography machines.  
Despite the development of a national cancer program in 2005, there is limited 
information on health determinants influencing screening rates. Furthermore, there is limited 
information on screening rates as breast and cervical cancer incidence and mortality rates 
continue to climb (Fouzanhafer et al., 2011; Krygier, Barrios & Muse, 2010). The only 
information publicly available for comprehensive breast cancer screening rates indicated a 75% 
participation rate in the 2005 national screening program that provides mammograms, clinical 
breast exams, and breast self-exams for women ages 40-69 every 2 years (ICSN, 2011). 
Currently the Ministerio de Salud Pública recommends that women in Uruguay ages 40-64 
should obtain a mammogram every year. 
Healthcare services 
The state has contracts with private healthcare providers to administer healthcare to 
individuals in clinics or hospitals throughout the country. Healthcare providers are paid through 
these contracts and also receive incentives for meeting specific healthcare goals within their 
practice (e.g., having 50% of your patients maintain healthy cholesterol levels). There are several 
health care services provided free of charge for all citizens such as mammograms and Pap tests, 
pregnancy tests, and preventive care for people under the age of 18. However, there is evidence 
that screening access may vary by location. A 2006 telephone survey with over 100 breast cancer 
experts in 12 Latin American countries, including Uruguay, found that the current access rate for 
mammography in Uruguay was 66.3% across the country and 47% at local cancer-centers 
(Cazap et al., 2008).  
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Health Literacy 
Health literacy, an individual’s ability to obtain, process, and understand basic health 
information and services for making appropriate health decisions (Ratzan & Parker, 2000), has 
been identified as contributing to lower health services use among Latinos in the U.S. Several 
skills and specific sets of knowledge are required to make informed health decisions. For 
example, making appropriate health decisions requires patients to utilize several health literacy 
skills such as locate health information, evaluate this information for credibility and quality, and 
analyze risks and benefits (IOM, 2002). These skills must be transferable across multiple health 
contexts and situations. Health literacy levels vary by individual and are shaped by individual 
factors such as formal education and neighborhood, and by personal factors such as life 
experiences (IOM, 2002).  
Currently there is no research on health literacy levels in Uruguay because this area of 
research was developed primarily in the U.S. and has been used in only a few South American 
countries (Pleasant, 2012). Therefore, I will describe trends based on the current U.S. literature 
which is further developed. Low health literacy has been linked to poorer health outcomes, 
higher rates of hospitalization, and less frequent use of preventive services such as Pap tests and 
mammograms among Latinas (Berkman et al., 2011; Flores & Acton, 2013; Garbers & Chiasson, 
2004; White, Chen, & Atchison, 2008). Individuals with lower health literacy levels are less 
likely to engage in preventive health behaviors and adhere to treatment and medication 
guidelines when compared to those with higher health literacy levels (Berkman et al., 2011). 
Doctors are often unaware of patients’ health literacy skills and therefore may overestimate 
patients’ health literacy levels (Bass, Wilson, Griffith, & Barnett, 2002; Lindau et al., 2002). 
Oftentimes, patients are embarrassed about their inability to understand health information and 
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make appropriate decisions which leads them to not disclose this to their physician. Furthermore, 
medical educational pamphlets, brochures, or handouts given to patients are often created for 
individuals with advanced reading levels (Davis, Michielutte, Askov, Williams, & Weiss, 1998). 
Older patients tend to have lower levels of health literacy and may experience cognitive or 
memory impairments which inhibits their ability to process health information and make 
appropriate health decisions (Wolf, Gazmararian, & Baker, 2005).  
Cultural, social, and familial (sociocultural) factors help shape attitudes and beliefs, 
which in turn influence health literacy (Otero-Sabogal et al., 2003). We learn to develop different 
attitudes and beliefs through social interactions and through social products of our culture such 
as books and television (IOM, 2002). Health literacy can serve as a bridge between developing 
literacy and other skills when it permeates social relationships and one’s environment. Health 
literacy consists of cultural attitudes, beliefs, and knowledge that shape our perceptions and 
definitions of health and illness, preferences, and stereotypes. When individuals from different 
cultural backgrounds interact, such as patients and healthcare providers, miscommunication can 
occur due to different attitudes, beliefs, and knowledge which can contributes to underutilization 
of health services and mistrust.  
Cultural and conceptual knowledge  
Two important elements of health literacy are cultural and conceptual knowledge. 
Defining and measuring these aspects of health literacy is important for understanding and 
predicting health behavior and improving health education (IOM, 2002). 
Cultural knowledge refers to information and ideas obtained through life experiences and 
social processes. Investigating cultural knowledge allows researchers to understand clients’ 
worldviews or values about their lives and breast and cervical cancer (IOM, 2002). Culture itself 
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is dynamic; therefore, cultural knowledge is continually changing and evolving because of our 
life experiences and daily interactions. These life experiences shape our cultural knowledge of 
health systems and structures (IOM, 2002). Oftentimes, differences in cultural knowledge may 
lead to misunderstandings between patients and physicians. For example, a physician notices a 
patient is reluctant to receive a regular mammogram despite her advisement for the procedure. 
The physician asks the patient why she does not want to obtain the procedure. The patient 
discloses that she is afraid that she will be diagnosed with breast cancer and die. The physician 
can then discuss the likelihood of cancer and how it develops with the patient to help dispel these 
myths.  
Conceptual knowledge is the learning and transmission of specific cultural knowledge 
into an individual’s larger concept of health. Individuals with higher conceptual knowledge are 
able to elaborate on systems, procedures, and information relating to health conditions and/or 
systems. Conceptual knowledge helps individuals interact and understand their exchanges with 
the health system and healthcare providers. For example, new immigrants may be unaware of 
federally funded health insurance because this service was not offered in their home country.  
For this study, we propose that cultural and conceptual knowledge encompasses attitudes, 
beliefs, emotions, and knowledge within the context of cultural values (Buki & Quintero-
Johnson, 2009; Figure 2). The health literacy framework will be used to examine these domains 
and the influence of participants’ characteristics on these domains. For this study, we will focus 
solely on the domain of breast and cervical cancer knowledge. 
Knowledge 
Knowledge is information or facts about a topic that can be tested or evaluated. This 
definition stems from Greek philosophy (Gower, 1997). Greek philosophers such as Plato and 
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Aristotle built philosophy around discovering through reason the laws of the universe. The 
scientific method was later developed by the writings of Bacon, Galileo, and Descartes, who 
used an inductive approach (Gower, 1997). The scientific method is a set of guidelines used 
within the sciences to determine whether a statement is true. Researchers acquire data through 
observations about a particular phenomenon (Gower, 1997). These data are then evaluated and 
tested to determine the certainty of the statement or knowledge.  
Knowledge allows individuals to make informed decisions. For example, a woman who 
has high levels of knowledge about breast cancer and the importance of screening is more likely 
to obtain a mammography screening than those with lower levels (Carter, Park, Moadel, Cleary, 
& Morgan, 2009; Buki et al., 2007; Ramirez et al., 2000). Specific knowledge about health 
systems or cancer prevention enables individuals to interact with the healthcare system more 
effectively and provides them with a schema (cognitive framework) for understanding 
patient/clinician interactions and screening. 
Current knowledge measures 
Extant breast and cervical cancer knowledge measures typically focus on screening 
guidelines and cancer symptoms. The few existing breast cancer knowledge measures consist of 
multiple dimensions or constructs of breast cancer knowledge. Stager (1993) developed a breast 
cancer knowledge instrument for Mormon women in Utah composed of the following 
dimensions: general knowledge and curability. Ondrusek and colleagues (1999) extended this 
work by creating a breast cancer knowledge scale to assess knowledge of breast cancer and 
genetic risk. The scale was developed using focus groups and an expert panel, and factor analysis 
was used to examine its overall structure. The scale consisted of the following factors 
(constructs): disease prevention and treatment, incidence and risk factors, primary and secondary 
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prevention, and genetics (Ondrusek et al., 1999). Most breast cancer knowledge measures have 
been developed using classical test theory or factor analytic approaches (Ondrusek et al., 1999; 
Stager, 1993). One limitation of these approaches is that they do not examine item-level 
properties (i.e., item discrimination and difficulty).  
Currently, there are no validated and reliable cervical cancer knowledge measures. Most 
researchers use measures that combine knowledge specific items with cancer attitude or belief 
questions. Furthermore, studies measuring cervical cancer knowledge are typically developed by 
researchers specifically for their study and are not replicated in other samples. Therefore, there is 
a great need to develop reliable and valid breast and cervical cancer knowledge measures using 
rigorous psychometric approaches that measure a latent variable and provide item information. 
I don’t know, yes, no responses 
Most knowledge scales use either “agree,” “disagree” or “yes,” “no” responses. The 
CLM-BCC knowledge items use a “yes” “no” “I don’t know” response format which does not 
have an obvious scoring rule that is more apparent with other types of data (e.g., ordinal or 
Likert-type scale). This is a drawback when investigators want to consider possible scoring 
options. Therefore, researchers may exclude “I don’t know” responses or collapse them into the 
“no” category (Anderson et al., 2010). Yet, these responses hold information that can help 
researchers understand their population and provide further information on the latent variable. 
There are two schools of thought on how to score “yes,” “no,” “I don’t know” responses in the 
political opinion literature. One body of literature indicates that “don’t know” responses fall 
between “no” and “yes” (Groothuis & Whitehead, 2002). Yet, Anderson and colleagues (2010) 
found that participants used “don’t know” responses as a guessing parameter in a national 
political opinion survey, meaning that “don’t know” was treated as a separate category removed 
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from “no” and “yes.” Given the limited measurement development on breast and cervical cancer 
knowledge scales in the literature it is imperative to explore the latent scaling metric of nominal 
responses, “yes” “no” “I don’t know” to determine an appropriate scoring rule.  
Current health literacy measures 
There are a handful of health literacy measures currently used in research and clinical 
settings. To date, no measures have been developed besides the CLM-BCC to measure cultural 
and conceptual knowledge. These measures are typically developed in the U.S. and focus only 
on measuring print literacy, oral literacy, and numeracy, which overlook the influence of 
sociocultural processes and health determinants on preventive health behaviors such as screening 
(Baker, 2006; Peerson & Saunders, 2009; Pleasant, McKinney, & Rikard, 2011). For instance, 
two of the most common health literacy measures are the Test of Functional Health Literacy in 
Adults; Parker, Baker, & Williams, 1995) and the Rapid Estimate of Adult Literacy in Medicine; 
Davis, Michielutte, Askov, Williams, & Weiss, 1998). These scales measure basic print literacy 
within a clinical setting. These measures do not account for the influence of social determinants 
on healthcare interactions and preventive health behaviors in an everyday setting that strongly 
influence health promotion (Peerson & Saunders, 2009). Furthermore, the field of health literacy 
measurement has faced criticism for developing new measures that are not based on the IOM’s 
health literacy framework and do not connect with the fields of clinical and applied health work 
(Pleasant, McKinney, & Rikard, 2011). Current recommendations suggest that new health 
literacy measures be built on a testable theory, have items with a range of difficulty levels and 
test well, and consist of latent multidimensional constructs that can be measured along a 
continuum (IOM, 2009; Pleasant et al., 2011). Additionally, these measures do not account for 
the extensive work in the breast and cervical cancer literature indicating that knowledge plays an 
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influential role in screening behavior. At this time, a short cultural and conceptual knowledge 
measure accounting for the influence of social determinants on cancer screening behaviors is 
needed in a clinical and health education setting to identify individuals in need of more health 
education. 
Order of Analyses 
 All analyses used in this study will be from IRT in order to fulfill the study’s specific 
aims. The order of analyses is as follows: Mokken scaling followed by IRT, and EIRM. Mokken 
scaling will be used to determine the dimensionality (or latent structure) and scalability of items. 
Building off of Mokken scaling all models will be analyzed by dimensionality using traditional 
IRT modeling and explanatory item response modeling. Explanatory item response modeling 
builds off of traditional IRT by indicating how scale properties (item location and discrimination 
parameters) change when adding in person covariates predicting theta.  
Item Response Theory 
Within the psychometric literature there are several measurement approaches that can be 
used to examine measurement properties. Both IRT and classical test theory (CTT) assume a 
unidimensional measurement structure. CTT assumes that the observed score (O) consists of the 
true score (T) plus overall error (E), using the following equation: O= T + E. Theoretically, the 
error component represents the variability that would occur if each respondent took the 
assessment several times without remembering previous times (Wilson et al., 2006). O and T 
represent the interaction between the instrument and the respondents’ knowledge level; however 
neither of these indicates the overall knowledge level directly (Wilson et al., 2006). Furthermore 
there is no information given about the difficulty level of the instrument or for specific items. 
This information is dependent on the number and types of individuals who take the measure. 
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Therefore, it is difficult to compare different instruments measuring the same aspects of 
knowledge and between groups who have different levels of education. Furthermore, raw item 
scores are treated as linear measures with the same standard error throughout their range which 
biases most statistical methods based on this assumption (Wilson et al., 2006).  
IRT uses item responses which creates a linear (logit) scale representing higher or lower 
breast cancer knowledge levels treating it as a latent variable. This allows the researcher to 
compare the relationship between the respondent location and item location on the scale of the 
latent breast cancer knowledge variable directly. The item location is modeled independently of 
the locations of other respondents in that group and has an estimated probability of endorsing 
that item. Item responses on instruments are used to estimate item locations and respondent 
locations, and standard errors. The measure can be interpreted as indicating the probability that a 
particular respondent with a particular estimated location will endorse a specific knowledge item. 
IRT allows us to compare similar knowledge tests across different populations that may have 
different education levels or vary individually. Furthermore the focus on items allows us to 
perform a more “extensive assessment of the functioning of response choices within items—the 
item categories—and the coverage of [knowledge] the instrument is supposed to measure” 
(Wilson et al., 2006, pp. i20). IRT assumes that an individual’s observed score is a based on the 
likelihood of answering the item correctly, given their item response which is a function of theta 
or true score, item traits, and their interaction. The two-parameter logistic (2PL) item response 
model is based on the following equation: 
𝜃𝑖 is… P(Yij =1) = 
𝑒𝑥𝑝
𝑎𝑗(𝜃𝑗−𝛽𝑗)
1+𝑒𝑥𝑝
𝑎𝑗(𝜃𝑗−𝛽𝑗)
. (1) 
Note. aj is the discrimination parameter for item j. βj  is the difficulty parameter for item j. 𝜃𝑖 is 
the knowledge level for person i. Yij is the item response for item j, person i. 
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In this equation the aj represents the direction and speed based on the increase from low 
to high predicted probabilities, and βj controls the location of item on the θ (theta) scale. In CTT, 
the overall trait score is measured by Cronbach’s alpha which measures the correlation between 
items on a scale whereas in IRT the latent knowledge score is measured by a theta score which 
considers the scale items and the individual’s responses to those items. Using IRT to improve a 
scale, better items are developed, whereas in CTT similar items are added to the scale to increase 
the reliability level. This overlooks the fact that a participants’ understanding of an item (or 
actual score) may be different from the item’s intended purpose (the construct intended to 
measure). Likewise, in CTT error is considered to be static across all participants whereas in IRT 
a more complex understanding of measurement error is used that considers error to vary across 
individuals. Therefore, taking an IRT approach helps determine CLM-BCC items that are 
performing well and others that may need refinement in order to use this measure with broader 
populations. Within IRT, there are different types of models that are used to analyze data. Two 
simple models are the 1 parameter logistic regression (1PL) or Rasch model and the 2 parameter 
logistic regression (2PL) or normal o-give model for dichotomous (binary) response items. 
1PL model 
The one parameter logistic regression model has an item location parameter (b), which is 
the point of variation on a theta scale (Embretson & Reise, 2000). Item difficulty values usually 
fall between -3 and +3 when theta is assumed to have a mean of 0 and a standard deviation of 1. 
Similarly, participant difficulty values typically fall between -3 and +3. Items with low b values 
are classified as hard items in which participants with lower knowledge levels have lower 
probabilities of correctly responding to an item. Items with high b values are considered easy 
items that all participants have a high probability of correctly responding to the item. This is 
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defined as the slope of an item characteristic curve (ICC) at the point of inflection. The ICC is a 
graph (see Figure 3) that indicates the probability that an individual endorses a specific response 
category as a function of the overall knowledge level which falls between zero and one (Stochl et 
al., 2012). In an ICC the level of knowledge increases as the probability of an individual 
endorsing a correct response to an item increases (Hambleton et al., 1991). The graph consists of 
an s-shaped curve to describe the relationship between the probability of a correct response to an 
item and the item knowledge. Parameter values for theta fall usually between -2 and +2. The 
equation below presents the 1PL or Rasch model equation adapted from Hambleton and 
colleagues (1991, pp. 12-13). 
Pi(θ ) = 
𝑒
(𝜃𝑖−𝑏𝑗)
1+ 𝑒
(𝜃𝑖−𝑏𝑗)
  i=1,2,…,n.(2) 
𝑃𝑖(𝜃) is the probability that a randomly chosen person, i, with 𝜃 or the specific 
knowledge level answers item j correctly. bj represents the item difficulty parameter which is 
also the item location parameter. n is the number of items on the test. e is the transcendental 
number (like 𝜋) whose value is 2.718 (correct to 3 decimals) and Pi (𝜃) is an S-shaped curve 
with values between 0 and 1 over the knowledge scale. According to the ICC, the bj parameter 
for an item is the point on the knowledge scale where the probability of a correct response is 0.5. 
The bj parameter value indicates the item location position on the ICC or along the horizontal 
axis. The lower the value of the bj parameter, the higher the knowledge level is needed for an 
examinee to have a 50% chance of choosing the correct answer, making it an easier item. Easy 
items are located to the right or the higher end of the knowledge scale and more difficult items 
are located to the left lower end of the knowledge scale. The lower asymptote of the ICC is zero 
which specifies that examinees with a very low knowledge level have a zero probability of 
answering the item correctly (Hambleton et al., 1991). The knowledge values are linearly 
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transformed to a meaningful scale to facilitate interpretation having a mean of 0 and a standard 
deviation of 1.  
Figure 4 below is an ICC for a 1PL model (Templin, 2012), all the b parameters (b1, b2, 
b3, b4) represent the item difficulty location for items 1-4 (b1 = item 1, b2 = item 2, b3 = item 3, b4 
= item 4) on the knowledge scale. In a 1PL model the a parameter is assumed to be constant 
across all items (i.e., a =1; 50% chance of getting the item correct) or at the point of inflection of 
curve. Moving from left to right, we can see that items decrease in difficulty level based on the b 
parameter value and also increase along the horizontal axis in terms of measuring more of the 
latent trait. This means that individuals with higher knowledge levels will be more likely to 
answer the most difficult item, item 1, compared to those with lower knowledge levels. 
Likewise, those with lower knowledge levels will have a higher likelihood of answering the 
subsequent items, 2-4 correctly because they are easier. 
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Figure 4. Item Characteristic Curves for 1PL model adapted from (Templin, 2012) 
2PL model 
The 2PL model builds on the 1PL model by adding an additional parameter, ai, known as 
the item discrimination which is a parameter to increase flexibility for modeling response 
probabilities and by adding a scaling constant, D, to make the logistic model resemble the 
normal o-give model on the ICC. When D = 1.7, values of Pi (𝜃) for 2PL models differ in 
absolute value by less than 0.01 for all values of 𝜃 (theta). The equation below represents the 
2PL model and is also adapted from Hambleton and colleagues (1991, pp.14-15) which means 
that parameters Pi (𝜃) and bi are defined the same as the 1PL. 
𝑃𝑖(𝜃) =
exp [(𝐷𝑎𝑖(𝜃−𝑏𝑖)]
1+exp[𝐷𝑎𝑖(𝜃−𝑏𝑖)]
,  
b1=-2, b2=-1, b3=0, b4=+1 
Item 1 Item 2 Item 3 Item 4 
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 i = 1,2,…,n. (3) 
The ai parameter is proportional to the slope of the ICC at the point bi on the knowledge 
scale. Items with steeper slopes are more useful for separating examines into different knowledge 
levels than are items with less steep slopes. An item is most discriminating for 𝜃 (theta) values 
near the item b parameter and least discrimination when 𝜃 are far from the item’s b parameters 
which allows researchers the ability to discriminate among examines near an knowledge level 
(theta) 𝜃.  
Figure 5 below is an ICC for a 2PL model (Templin, 2012). Similar to Figure 4, the a 
parameters (a1, a2, a3, a4) represent the item discrimination location for items 1-4 (a1 = item 1, a2 
= item 2, a3 = item 3, a4 = item 4) on the latent knowledge scale. The b parameters are defined 
similarly to Figure 4. Looking along the horizontal axis (𝜃) we can see that when theta is -1 and 
at the vertical axis when the p=.50 (50% chance of getting the item correct) or at the point of 
inflection of curve, items 1 and 2 are harder and measure less knowledge than items 3 and 4 
because they have a probability lower than 1 (when looking at the vertical access) unlike the 
curves in Figure 4 for these items. Looking along the horizontal axis when theta = +2, we can see 
that item 1 is now more difficult than item 4 because it has a probability lower than 1 unlike the 
curves in Figure 4 for these items, which also means that item 1 measures less knowledge than 
item 4. 
46 
 
 
Figure 5. Item Characteristic Curve for 2PL model adapted from Templin (2012) 
Multilevel Modeling 
 Multilevel models are complex statistical models that recognize data hierarchies that 
allow for residual or unobserved components or effects at each level in the hierarchy. This 
analysis is commonly used for nested data. For example, a two-level model with data collected 
from women across 20 different communities can be analyzed across different levels to account 
for dependency within the data, reduce standardized error, and make appropriate inferences 
(Snijders & Bosker, 2012). The data can be examined at micro level (level 1) across women and 
at the macro level (level 2) of communities simultaneously. The residual variance is partitioned 
between the women (variance of individual level residuals) and community component (variance 
of community level residuals) (Snijders & Bosker, 2012). The community residuals or 
b1=-2, a1=.5, b2=-1, a2=1,  
b3=0, a3= .5, b4=+1, a4=1  
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‘community effects’ represent unobserved community level characteristics that affect women’s 
knowledge. This framework can be applied to IRT models to take a person-centered or 
explanatory approach. 
Explanatory item response modeling 
A simple Rasch model (a basic one parameter logistic regression item response model) 
uses responses to items to estimate respondents’ latent knowledge levels and item difficulties on 
the same scale. One limitation of using this model is that it is doubly descriptive meaning that 
each person and item has its own effect. Other models can include an explanation of person 
effects by taking an explanatory or person-centered approach. For example, when both person 
and item properties are included in the model, it is “doubly explanatory.” Explanatory item 
response modeling (EIRM) explores the relationship between item responses and other variables 
(De Boeck & Wilson, 2004). This approach allows researchers to model how properties of the 
items and examinee characteristics influence item responses (De Boeck & Wilson, 2004). Most 
item response models are special cases of generalized linear or nonlinear mixed models allowing 
the similarities and differences between models to be described in terms of the kinds of 
predictors (item properties, person properties, and interactions of item and person properties) and 
the kinds of weights they have, like the regression model. The measure can be interpreted as 
indicating the probability that a particular respondent with a particular estimated location on the 
latent knowledge variable will endorse a specific knowledge item (Wilson, Allen, & Li, 2006). 
This psychometric approach is a special type of item response modeling which allows us to 
model parameters for item location (a) and item knowledge (b) based on the latent variable or 
theta 𝜃, (i.e., knowledge). Item responses can be paired with variables that relate to items (item 
predictors) and to examinees (person predictors). We are able to simultaneously model item 
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difficulty and knowledge and examine the effect of covariates (person or item covariates) on 
these item parameters by adding in item and/or person covariates. Furthermore we are able to 
estimate theta by putting theta into a regression model that accounts for random error.  
Given the equation for theta below, which is adapted from De Boeck and Wilson (2004), 
𝜃𝑗  is an individual’s knowledge level. 𝛾01 is the coefficient for the predictor 𝑥𝑗 for person j in the 
model. 𝜀𝑗 is the residual part of the error for person j. 𝑎𝑖 is the discrimination parameter for item 
i. 𝑏𝑖is the difficulty parameter for item i, 𝑥𝑖𝑗 is the person coefficient for the predictor for item i 
and person j and 𝑥𝑗 is the coefficient for person j. 
 𝜃𝑗 = 𝛾00 + 𝛾01𝑥𝑗 + 𝜀𝑗, 
𝑎𝑖 = 𝑎00 + 𝑎01 + 𝑥𝑖𝑗, 
𝑏𝑖 =  𝑏00 + 𝑏01 + 𝑥𝑖𝑗, (4) 
The EIRM equation above is a more appropriate model because we are able to perform model 
fitting and estimation simultaneously meaning that it is done in one process. This is better in 
terms of estimating with error because it reduces the amount of error introduced into the model. 
According to the EIRM equation below, Yij is the likelihood that person j answered item i 
correctly based on their response k, given their overall knowledge level. bj is person j’s cancer 
knowledge and aik is the coefficient for “slope” for item i and response k etc… 
P(Yij=k|θj) = 
𝑒𝑥𝑝⌊𝑎𝑖𝑘𝜃𝑗+𝑏𝑖𝑘⌋
∑ 𝑒𝑥𝑝⌈𝑎𝑖𝑘𝜃𝑗+ 𝑏𝑖𝑘⌉
, 
𝜃𝑗 = 𝛾01𝑥𝑖𝑗 + 𝜀𝑗, 
𝑎𝑖𝑘 = ⋯ and 𝑏𝑖𝑘 = ⋯ (5) 
Where 𝜀𝑗 is normally distributed which is assumed to have a mean of 0 and a standard deviation 
of 1, N(0, 1). 𝑎𝑖𝑘is the discrimination parameter for item i and response k. 𝑏𝑖𝑘 is the difficulty 
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parameter for item i and response k. In the model for theta above, covariates are added into the 
model to observe the influence of these on specific knowledge items in terms of theta 
(knowledge). This approach provides precise information on how participant characteristics can 
influence item responses and knowledge taking a person-centered or explanatory approach which 
is beneficial for survey development and refinement. 
Mokken scale analysis  
Mokken scaling analysis (MSA) is utilized to scale individuals and items on a 
unidimensional, binomial or ordinal scale. The Mokken approach to scaling is a part of a family 
of IRT models. The MSA model checks the assumptions of parametric IRT models of scale 
items: unidimensionality, latent monotonicity, and local independence for all popular parametric 
IRT models (e.g., Rasch or 1PL, 2PL). This procedure can be used for both polytomous 
(meaning variables that contain more than 2 categories) and dichotomous (binary) items on a 
unidimensional parametric scale. MSA can also be used to determine multiple unidimensional 
scales simultaneously. One advantage of MSA is that it relaxes some of the more restrictive 
assumptions of non-linear behavior of response probabilities that are often found in IRT 
parametric models. This allows items with increasing, but less regular ICC curve shapes to be 
included in the analysis. However, MSA only allows researchers to obtain information about the 
item location, but not information on the knowledge estimates or the item locations themselves. 
Scalability 
MSA indicates poor items (items which are not scalable) or scalability. This process 
allows researchers to extract a unidimensional set of items from a larger pool and see whether 
additional items can be added to an existing scale without changing the dimensionality of the 
scale. For each pair of items an item-pair of scalability coefficients are produced, Hij. In MSA, 
50 
 
items belonging to the same Mokken scale should have positive item-pair scalability coefficients 
and have a test and item scalability coefficient (H) greater than some positive lower bound c.
1
 
These can be interpreted similarly to discrimination (a) parameters in parametric IRT. Mokken 
(1971) proposed that a scale is considered weak if the test and item scalability coefficient (H) are 
greater than c =.3, H . 3 ≤ 𝐻 < .4, and is considered moderate if . 4 ≤ 𝐻 < .5, and a scale is 
considered strong if 𝐻 >  .5 (Molenaar, Sijtsma, & Boer, 2000). 
Item selection 
MSA partitions a set of items into Mokken scales and identifies a set of unscalable items. 
A Mokken scale uses Guttman scaling to identify a set of items based on a positive lower bound 
c. All inter-item covariances are strictly positive where H indicates the degree to which the item 
is scalable and 𝐻 ≥ 𝑐 > 0. This partitioning is done using an automated item-selection 
algorithm. Two parameters, the lower bound c
1
 and the nominal significance level, are specified 
by the researcher. Lower bound c defines the minimum value of coefficients H in the Mokken 
scale. The recommended default value is c = .3 (Molenaar et al., 2000). Parameter α is the 
nominal significance level of the inequality tests used in the automated item selection algorithm 
and its recommended default value is .05.  
Latent monotonicity 
MSA also tests for the assumption of latent monotonicity meaning that the probability of 
having a positive response or endorsing an item will increase as the participant’s latent 
knowledge level increases. In other words, a participants’ probability of endorsing an item on a 
scale correctly increases for each item she answers correctly and the more items she endorses 
correctly the higher her knowledge level. A participant’s answers or responses to items represent 
                                                     
1
 The coefficient, C, refers to an outlier for Mokken coefficient and is considered as distinct from the c 
parameter in IRT which represents pseudo-guessing or a lower asymptote of the ICC. 
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their overall latent knowledge level. The H
T
 coefficient or Htrans is used to measure the distance 
between response functions or ICCs (Watson, Wang, & Thompson, 2014). The closer they are 
the likelihood of intersection (violations of monotonicity) increases and the likelihood of latent 
monotonicity (IIO or invariant item ordering) decreases (Watson et al., 2014). H
T 
can be 
interpreted similarly to the scale coefficient, H
T . 3 ≤ 𝐻 < .4, and is considered moderate if 
. 4 ≤ 𝐻𝑇 < .5, and a scale is considered strong if 𝐻𝑇 >  .5 (Watson et al., 2014). 
Non-intersection 
The three aforementioned assumptions are sufficient for most applications of non-
parametric IRT; however the assumption of non-intersection is also useful for polytomous items 
(Stochl, Jones, & Croudace, 2012). MSA assumes that item trace lines or ICCs do not intersect 
across θ (theta). Item trace lines are allowed to touch locally and even coincide in an extreme 
case. Items are ordered by the probability of correctly answering that item so that the probability 
level decreases through the exam, meaning that item difficulty level increases with each 
subsequent item (Stochl et al., 2012; Van der Ark, 2007). 
Scale partitioning 
The Mokken scaling package (MSP; Van der Ark, 2007) in Open R has two algorithms 
for the automated item selection procedure, the hierarchical clustering algorithm (AISP) and the 
genetic algorithm (GA; Straat et al, 2013). These allow the researcher to partition items into 
more than one scale, allowing for multidimensional scaling (van der Ark, 2012). This function of 
scale partitioning is not considered as part of the original Mokken framework, but is a handy 
feature for exploring and confirming scale structures. The hierarchical clustering algorithm starts 
by taking 2 items having the largest Hij (inter-item correlation) value and adding in items that 
meet the criteria into the set until no more can be added. The remaining or unselected items are 
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used to create another Mokken scale and are assumed to measure another latent dimension. This 
process is repeated until no more scales can be created from the items. The genetic algorithm 
was developed to overcome some of the problems encountered with the hierarchical algorithm. 
Straat, Van der Ark, and Sijtsma (2013) found that the hierarchical algorithm (AISP) made it 
difficult to tell if ideal partitioning was obtained and sometimes it did not produce Mokken 
scales because Hij coefficients could be less than the lower bound, c. However, this function does 
not allow the researcher to check for optimal partitioning and also overlooks the possibility that 
some items might not be selected because their Hij coefficients might be slightly less than the 
lower bound or c (van der Ark, 2012). The genetic algorithm mimics the biological principle of 
natural selection, selecting the best fitting items which may be ideal in situations where 
hierarchical clustering is not. GA evaluates several partitionings of items simultaneously by 
“maximiz[ing] the objective function subject to the side condition that each selected cluster is a 
Mokken scale.”(Straat et al., 2013, p.83). GA produces results that are considered a Mokken 
scale by definition without having the highest H values possible, but having maximum length 
(Straat et al, 2013). Findings from item selection algorithms can be compared to determine the 
ideal Mokken scales and scaling dimensionality.   
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 CHAPTER 3 
 METHOD 
This chapter describes the study methodology implemented in the current study. The 
dataset utilized in the study is described first, followed by preliminary statistical analyses. Data 
analytic procedures which address the specific aims of this study are discussed in detail, 
including descriptions of fit criteria for MSA and EIRM and the software used in this study. 
Survey 
The Cancer Health Literacy Measure-Breast and Cervical Cancer-Uruguay ([CLM-BCC]; 
Buki & Reich, 2011; Buki Yee, & Reich, 2011) (Appendix A) represents a collaborative multi-
site project conducted in Uruguay with the Universidad Católica Uruguay and the Comisión 
Honoraria de Lucha contra el Cáncer (CHLCC). This study was approved by the IRB at the 
University of Illinois at Urbana-Champaign. The CLM-BCC is a questionnaire created from 
extensive research and a previous study using Latinos in the U.S. (Buki & Yee, 2009). The 
screener was adapted to fit cultural and linguistic nuances of Uruguay through focus groups and 
pilot testing with a local sample of women. It is a prospective investigation of psychosocial 
factors and breast and cervical cancer screenings outcomes among women in Uruguay. The 
CLM-BCC knowledge items analyzed in this project are listed below by the purported subscales.  
Breast cancer knowledge 
The breast cancer knowledge items assess women’s knowledge of breast cancer and 
screening procedures. The breast cancer knowledge subscale is composed of 12 items (items 99-
108) with a nominal (multiple categories) response set of “no,” “yes,” and “I don’t know.” 
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Cervical cancer knowledge 
Similar to the breast cancer knowledge items, these items assess women’s knowledge of 
cervical cancer and screening procedures, which consist of 10 items (items 71-82) with a 
nominal response set of “no,” ”yes,” and “I don’t know.” 
Study Participants  
Data was collected from a total of 411 women living in five areas of Uruguay: Artigas, 
Flores, Maldonado, Montevideo, and Treinta y tres (for a map of Uruguay see Appendix). 
Inclusion criteria included being a women, 40 years of age or older (M = 50.6 SD = 7), and a 
native of Uruguay. Convenience sampling from local medical and community centers were used 
to recruit participants based on whether they were up to date with breast and cervical cancer 
screenings. Researchers planned before selecting participants to have approximately 50% of the 
sample up to date on their screenings.  
Data Collection 
Data collection was conducted over 2 months in 2011 by community-academic 
partnerships. Staff working at local community centers was trained by researchers from the 
Universidad Católica Uruguay and the Comisión Honoraria de Lucha contra el Cáncer to 
conduct the pencil and paper survey (CLM-BCC) in Spanish. The questionnaire took 
approximately 2 hours for women to complete. No incentives were given to participants for 
being a part of the study. 
Data preparation and preliminary analyses 
Before analyzing the CLM-BCC data, the raw data was cleaned and prepared for use in 
the current project. Descriptive characteristics of the CLM-BCC data were computed prior to all 
analyses that included frequencies and variable distributions. One participant was identified as an 
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outlier with extreme values in the data set, therefore this participant’s data was removed from 
subsequent analyses. Prior to explanatory item response modeling odds ratios were analyzed 
between covariates to determine the pattern of the data.  All “I don’t know” responses were 
combined with no for explanatory item response models to create binary models consisting of 
correct and incorrect responses to improve model fitting. 
Data analyses 
Address Specific Aim 1: Determine if there are any unscalable CLM-BCC item(s), and 
determine the unidimensionality of CLM-BCC knowledge subscales. 
Mokken scale analysis 
Mokken scale analysis (MSA) assessed whether the CLM-BCC is composed of two latent 
variables, (a) breast cancer knowledge and (b) cervical cancer knowledge. MSA is typically used 
with ordinal or binary item responses therefore, for knowledge item different ordering 
combinations were used to determine the scales’ natural ordering or latent metric. Various 
procedures of MSA are described below. 
Scalability 
MSA provides the H coefficient that represents the scalability of items and the overall 
test; it ranges from 0-1. If H = 1 the test data follow a perfect Guttman scalogram. A scale is 
considered weak if the test scalability coefficient, H, .3 ≤ 𝐻 < .4, and it is considered moderate 
if . 4 ≤ 𝐻 <  .5, and a scale is considered strong if 𝐻 > .5 (Van der Ark, 2007). There are item 
specific scalability coefficients and an overall test scalability coefficient, H. If item and test 
scalability coefficients did not meet the moderate or strong test scalability coefficient criteria 
based on the scalability confidence interval range it was eliminated from further analyses.  
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Item selection and scale partitioning 
Item partitioning was done using an automated item-selection algorithm. For item 
selection the lower bound c, defines the minimum value of coefficients H in the Mokken scale. 
The recommended lower bound (c = 3) and significance level of .05 were used for scale 
partitioning (Molenaar et al., 2000).  
MSP uses two algorithms for the automated item selection procedure, the hierarchical 
clustering algorithm (AISP) and the genetic algorithm (GA), which allow the researcher to 
partition items into more than one scale, allowing for multidimensional scaling (van der Ark, 
2012). Item selection findings using the AISP and GA were compared to determine the ideal 
Mokken scales or consistency between methods in addition to scaling dimensionality.     
Latent monotonicity 
To investigate latent monotonicity participants’ responses were put into item rest score 
groups based on similarities in their total scale score (Van der Ark, 2007). MSA confirms that 
item rest score groups occur in a positive trend for the selected items, meaning that the item trace 
lines will indicate the probability of a positive response to an item should increase as the latent 
trait increases. All scale items were checked for violations of monotonicity, only scales without 
any violations were selected as final models. The H
T
 or (Htrans) coefficient indicates the level 
that the monotonicity criteria is met falling between 0-1, scales were selected that were greater 
than or equal to .3 as recommended in the literature (Watson et al., 2014). 
Non-intersection 
Non-intersection can be explored in Mokken scaling when the ordering of items is 
important in terms of difficulty level to confirm that it is the same for all levels of the trait 
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measured by the test (van der Ark, 2012). In this case, EIRM was used to determine the difficulty 
and item discrimination level therefore non-intersection in the data was not explored.  
Address Specific Aims 2, 3, & 4: Test and explain breast and cervical cancer knowledge 
item responses and their relationship with individual level variables. Examine the influence of 
participants’ characteristics (mammography screening status, Pap test status, age, education 
level, area of residence, etc.) and item characteristics on item responses which are assumed to be 
independent. Demonstrate the benefit of using EIRM over a traditional IRT approach. 
Item response modeling 
 Traditional item response models were performed on CLM-BCC knowledge items 
followed by EIRM models to determine if there were differences in knowledge scores when 
accounting for participant characteristics. These covariates (fixed effects) were added into the 
second level of the model to determine whether these items significantly influence item 
responses (De Boeck, & Wilson, 2004). For provinces, only the two with the highest distribution 
percent of cases (Maldonado and Montevideo for breast cancer and Artigas and Treinta y tres for 
cervical cancer) were added as fixed effects into the models. To improve model fit, “no” and “I 
don’t know responses” were collapsed into one category (incorrect) to create two categories 
correct (yes) and incorrect. 
 Measures of fit  
Model fit consists of multiple components because there is no single best way to 
determine fit. Based on the literature model fit will be determined using absolute, relative, and 
quality of solution techniques to select the most parsimonious models. 
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Absolute fit 
The likelihood ratio test is a measure of absolute fit which indicates how well a model fits 
the data overall. It does this by comparing the fit of two models using the ratio of the maximized 
likelihood functions which includes: (1) the maximum likelihood when parameters satisfy the 
null hypothesis, (2) the maximum likelihood when parameters are unrestricted (Agresti, 2007). 
The test statistic compares the alternative model to a previous or null model. The symbol,ℓ0, 
represents the null or simpler model, and ℓ1,denotes the alternative model. 
The likelihood ratio test statistic equals: 
−2 log  (ℓ0 − ℓ1). (6) 
The test statistic value is nonnegative and follows the chi-square distribution. The degrees of 
freedom are equal to the difference in the number of model parameters for the simpler and 
alternative model. Significance testing is used to determine if the alternative model provides a 
better fit than the null to a simpler model. This test can only be used when the simpler model is 
nested within the alternative model. Therefore, other fit criteria will be utilized as well. 
Relative fit 
Information criteria indices are based on the maximum log-likelihood of models and can 
be used to compare models in terms of how well a model fits the data and the model’s 
complexity. One index, the Akaike information criterion ([AIC]; Akaike, 1974), is based on 
information theory which provides an estimate of the information that is lost from a statistical 
model when this is used to represent data (Mulaik, 2009). The Bayesian Information Criterion 
Index ([BIC]; Schwarz, 1978) is based on Bayesian theory. Both the AIC and BIC are used to 
determine the best and most parsimonious model. AIC and BIC are measures of relative quality 
of a statistical model. AIC judges a model by how close its fitted values are to the true expected 
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values, which is indicated by a certain expected distance between the two. The AIC “penalizes” a 
model for having too many parameters (Agresti, 2007). The optimal model has fitted values 
closest to the true outcome probabilities; therefore the preferred model is the one with the 
minimum AIC value. BIC judges a model based on asymptotic approximations of the fitted 
model (Burnham & Anderson, 2004). Therefore, a minimum BIC value corresponds with the 
most plausible model based on the data (Burnham & Anderson, 2004). BIC is more stringent 
than AIC, therefore BIC tends to favor simpler models and AIC favors more complex models. 
Unlike the likelihood ratio test, models do not need to be nested in order to compare their fit. 
Both fit indices were used in these analyses to determine the best relative model fit. 
Quality of Solution 
Item fit indicates how closely the predicted item models fit the data. Standard errors and 
parameter estimates will be examined in all models to indicate scale items that contribute 
substantially to the model. The gradient of the log-likelihood function at the ending values of the 
parameters provides information about convergence. At the end of the iterations, the gradient 
(first-order partial derivatives) should be less than or equal to zero which indicates that the model 
has achieved its maximum and is considered a well-behaved data set (SAS, 2011). Items with 
non-zero gradient values indicate model non-convergence to the maximum of likelihood (SAS 
Institute, 2011). Item discrimination or a parameter estimates with p-values greater than .05 were 
considered in final model selection as these indicate that the item is not capturing or 
discriminating theta. Also, standard errors were checked for a reasonable size as overly large 
values tend to indicate an un-identified model.  
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Software 
Stata version 12 SE was used to compute preliminary descriptive analyses. The Mokken 
scaling package (MSP) in Open R was used to perform Mokken scaling (van der Ark, 2007). 
SAS PROC NLMIXED software, Version 9.3 of the SAS System for Windows was used to 
perform item response and explanatory item response modeling (SAS Institute, 2011). The 
NLMIXED procedure utilizes maximum likelihood estimation via adapted or nonadaptive 
Gaussian quadrature numerical integration to fit nonlinear mixed models in which fixed and 
random effects can be entered both linearly and nonlinearly (SAS Institute, 2011). The Newton –
Raphson optimization with line search or Quasi-Newton optimization techniques were used to 
estimate parameters.  
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CHAPTER 4 
RESULTS 
Overview 
This chapter describes the overall study findings. These results are described in 
sequential order moving from sample characteristics, descriptive analyses to model fitting. Basic 
descriptive statistics for the sample are presented first followed by each knowledge domain. This 
is followed by Mokken scaling findings and explanatory item response model findings. Final 
Mokken scale items can be found in Table 13. Results for breast cancer knowledge items are 
presented first followed by cervical cancer knowledge items.  
Uruguayan Women’s Characteristics 
Table 3. Uruguayan women's characteristics 
Characteristics 
Mean (sd) 
or percent 
Years of education 10.41 (4.3) 
Age 50.6 (7.0) 
In a relationship
a  
(%) 64.4 
Had children 92.0 
Location:   
  Maldonado (%) 19.5 
  Montevideo (%) 19.3 
  Flores (%) 21.0 
  Artigas (%) 19.5 
  Treinta y tres (%) 20.7 
Family history of breast cancer (%) 23.2 
Family history of cervical cancer (%) 10.0 
Performed breast self-exam (%) 79.0 
Participated in cancer education (%) 38.6 
Up to date for Pap test (%) 62.8 
Up to date for mammogram (%) 51.0 
Note: aParticipant reported being in a relationship, civil union, or 
married. 
 
62 
 
In the current dataset (N = 410), 51% of women were up to date for their mammogram 
screenings (within the past 2 years) and 62.8 % were up to date for Pap tests (within the past 2 
years), the mean years of women’s education was 10.41 (SD = 4.3), and 92% of women reported 
having children. A little over half of the sample was in a relationship (64.4%). In terms of 
location, approximately 20% each of the sample resided in the following provinces: Maldonado 
(19.5%), Montevideo (19.3%), Flores (21.0%), Artigas (19.5%), and Treinta y tres (20.7%). 
Approximately one quarter of the sample reported a family history of breast cancer (23.2%) and 
ten percent had a family history of cervical cancer. In terms of cancer screening experience, 
38.6% of the women reported participating in a cancer screening education workshop and 79% 
reported performing a self-breast exam.  
Breast Cancer Knowledge 
Table 4. Breast Cancer Knowledge Items 
  Categories 
  No Yes DK 
Item n % N % n % 
71
ii
 44 10.7 305 74.4 60 14.6 
72
i
 55 13.4 331 80.7 24 5.9 
73 103 25.1 139 33.9 168 41.0 
74 4 1.0 394 96.1 12 2.9 
75 6 1.5 393 95.9 11 2.7 
76 34 8.3 332 81.0 44 10.7 
77
ii
 100 24.4 223 54.4 85 20.7 
78
i
 34 8.3 361 88.1 15 3.7 
79 21 5.1 327 79.8 62 15.1 
80 15 3.7 366 89.3 29 7.1 
81 53 12.9 337 82.2 20 4.9 
82
ii
 187 45.6 93 22.7 129 31.5 
Note: DK="I don't know". i item was reverse-scored. iiItem had 
missing data. 
According to Table 4, a majority of the participants correctly answered or answered yes 
for all questions. Items 71, 72, 76, 78, 79, 80, and 81, the “no” and “I don’t know” categories are 
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about 1/3 or less of responses (or much smaller when compared to yes category). Which means 
that possibly the “I don’t know” category might not be necessary. The limited “no” and “I don’t 
know” or incorrect responses for some items may mean that these are easier than others. 
Breast cancer Mokken scaling 
In order to fulfill specific aims 1 and 2 Mokken scaling was performed on breast and 
cancer knowledge items. An initial exploratory Mokken scale analysis was done using 12 breast 
cancer nominal response items (71-82). Three different combinations of item response ordering 
were performed because the latent scaling metric is unknown which are noted by the 
combination number. Subscales with more than 3 items were used for confirmatory analyses as 
recommended in the literature (Shenkin et al., 2014). 
Combination #1-exploratory analyses 
Findings indicated that there were possibly three (self-breast exam, self-detection, and 
breast cancer symptoms; Table 5) subscales when responses were ordered as, “no,” “yes,” and “I 
don’t know.” Investigations of latent monotonicity (or invariant item ordering [IIO]) indicated 
that 2-3 items depending upon the algorithm (items 78, 79, and 80 for the genetic [GA] and items 
81 and 82 for the AISP) that were unscalable and had several violations. The overall scale had 
very low scalability (H=0.17) and all item scalability coefficients, H, were below.3. The scale 
also had low monotonicity (H
T
=0.04) with several violations of monotonicity which 
demonstrates the need to explore a multidimensional construct (Emons et al., 2010; Sijitsma & 
Molenaar, 2002). Therefore, dimensionality was examined in the next step of the analyses for the 
scales.  
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Confirmatory analyses 
Despite having acceptable scalability (H=0.54) the self-breast exam scale indicated by the 
AISP and GA (74, 76, 77) did not fulfill the monotonicity assumption (H
T
=0.02) in the first 
confirmatory analysis. Analyses indicated that item 74 needed to be removed in order to meet 
this assumption. With only two items remaining this subscale was removed from further 
analyses. The GA self-detection subscale (72, 75, 82) had acceptable scalability (H=0.37), yet 
low unacceptable monotonicity (H
T
=0.06). The GA self-detection scale analyses indicated that 
item 72 needed to be removed in order to meet this assumption. With only two items remaining 
this subscale was removed from further analyses. The AISP generated breast cancer symptoms 
subscale (71, 72, 73) had acceptable scalability (H=0.34), yet had unacceptable monotonicity 
(H
T
=0.08).  
Table 5. Combination #1 
Dimensions Algorithm Items H
 
(S.E.) Monotonicity? H
T
 
Self-breast Exam GA and AISP 74, 76, 77 0.54 (.08) Yes 0.02 
Self-detection  GA 72
i
, 75, 73 0.37 (.06) Yes 0.05 
Breast cancer 
symptoms 
GA 71, 72
i
, 73 0.34 (0.5) Yes 0.07 
      Note: 
i
Reverse-coded item. 
Combination #2-exploratory analyses 
 Given literature findings indicating that “ I don’t know” responses fall in between “yes” 
and “no” this relationship was explored further in mokken scaling (Groothuis & Whitehead, 
2002).  Findings indicated that there was possibly one subscale when responses were ordered as 
“no”, “I don’t know”, “yes.”  Investigations of latent monotonicity (IIO) indicated that 5 items 
(items 71, 73, 79, 81, and 82) were unscalable and had several violations. The overall scale had 
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very low scalability (H=0.11) and all item scalability coefficients, H, were below.3. The scale 
had low, but acceptable monotonicity (H
T
=0.33) with several violations of monotonicity which 
demonstrates the need to explore a multidimensional construct (Emons et al., 2010; Sijitsma & 
Molenaar, 2002). There were only 3 items in the scale so no further analyses were explored. 
Combination #3-exploratory analyses 
Findings indicated that there were possibly two subscales based on the GA and 1 subscale 
based on the AISP when responses were ordered as, “yes,” “no,” “I don’t know.”  Investigations 
of latent monotonicity (IIO) indicated that 4 items (items 72, 79, 81 and 77 for the AISP and 82 
for the gene) and were unscalable and had several violations (Table 6). The overall scale had low 
scalability (H=0.24) however, most item scalability coefficients, H, were below.3. The scale had 
acceptable monotonicity (H
T
=0.36) with several violations of monotonicity which demonstrates 
the need to explore a multidimensional construct (Emons et al., 2010; Sijitsma & Molenaar, 
2002). Therefore, dimensionality was examined in the next step of the analyses.  
Confirmatory analyses 
The GA produced breast cancer self-detection subscale (items 74, 75, 76, 77) indicated 
moderate acceptable scalability (H=0.48) and monotonicity (H
T 
=0.69; Table 6). The GA 
generated breast cancer other detection subscale (items 71, 73, 78, 80) indicated acceptable 
scalability (H=0.38) and monotonicity (H
T 
=0.63). The AISP breast cancer knowledge scale 
(items 71, 73, 74, 76, 78, 80) had acceptable scalability (H=0.34) and acceptable monotonicity 
(H
T 
=0.56) with no violations. All H item values were greater than 0.3 (Table 7). Yet, logically 
the GA subscales made the most sense therefore these were considered the best fit for the breast 
cancer knowledge items and had stronger H and H
T
 values. 
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Table 6. Combination # 3 
Dimensions Algorithm Items H (S.E.) Monotonicity? H
T
 
Breast cancer self-
detection 
GA 74, 75, 76, 77 0.48 (.05) Yes 0.70 
Breast cancer other 
detection  
GA 71, 73, 78
i
, 80 0.38 (.06) Yes 0.63 
Breast cancer 
knowledge 
AISP 
71, 72
i
, 73, 74, 76, 
78
i
, 80 
0.34 (.04) Yes 0.56 
Note: 
i
Reverse-coded item. 
Table 7. Scalability Coefficients for Final Models 
Breast Cancer Self-Detection Scale 
 
Item H S.E. 
 
 
74 0.44 0.08 
 
 
75 0.31 0.10 
 
 
76 0.54 0.06 
 
 
77 0.54 0.06 
 
  Total H 0.48 0.05   
Breast Cancer Other Detection Scale 
 
Item H S.E. 
 
 
71 0.37 0.06 
 
 
73 0.33 0.08 
 
 
78 0.39 0.07 
 
 
80 0.43 0.07 
 
  Total H 0.38 0.06   
 
Breast cancer knowledge explanatory item response modeling 
Breast cancer self-detection scale 
To fulfill specific aims 3-5 explanatory item response models were fit to the breast cancer 
self-detection scale items. The likelihood ratio test indicated that the 2PL was a better fitting 
model when compared to the 1PL, (𝜒2(4) = 9.8, 𝑝 < 0.05). Furthermore, the traditional IRT 
model was significantly improved upon by adding in person covariates to predict theta. The 2PL 
model with up to date (obtaining a mammogram in the past 2 years) and breast cancer family 
history was a better fitting model when compared to the 2PL, (𝜒2(2) = 72. , 𝑝 < 0.0001). The 
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information criteria (AIC= 1073.2, BIC= 1121.3) indicates that items 74, 75, 76, and 77 in 
addition to the covariates or fixed effects for women who are up to date for mammograms, and 
have a family history of breast cancer contributed to the breast cancer self-detection knowledge 
model (Table 8). For the other models (2PL with covariates, up to date, breast cancer family 
history, and cancer education; 2PL with covariates up to date and Montevideo; 2PL with the 
covariates up to date, Maldonado, and self-breast exam; and the 2PL with the covariate up to 
date; Table 12) the covariates cancer education and residing in Montevideo (province with the 
highest breast cancer case distribution) failed to significantly explain the breast cancer self-
detection knowledge variance. 
According to the EIRM equation below, Y is the response variable consisting of correct 
(“yes”) and incorrect (“no” or “I don’t know”). Y indicates the likelihood that person j answered 
item i correctly based on their response 1, given their overall breast cancer self-detection 
knowledge level. bj is person j’s cancer knowledge and ai is the coefficient for the “slope” for 
item i etc…For the model, parameter b indicates item difficulty and a indicates the item 
discrimination and the number represents the item number on the CLM-BCC survey (see Table 
7).  
Equation for 2PL model with the covariates up to date and breast cancer family history: 
𝑃 (𝑌𝑖𝑗 = 1│𝜃𝑗  𝑎𝑛𝑑 𝑢𝑝𝑡𝑜𝑑𝑎𝑡𝑒 𝑎𝑛𝑑 𝑏𝑐 𝑓𝑎𝑚𝑖𝑙𝑦 ℎ𝑖𝑠𝑡𝑜𝑟𝑦) =  
𝑒𝑥𝑝⌊𝑎𝑖𝜃𝑗+𝑏𝑖⌋
∑ 𝑒𝑥𝑝⌈𝑎𝑖𝜃𝑗+ 𝑏𝑖⌉
. (7) 
The equation below for theta below includes the parameters for the covariates (𝛾1𝑎𝑛𝑑 𝛾2) given 
items i thru p (𝛾𝑖𝑗 … 𝛾𝑝𝑗) into the model for 𝜃𝑗which will possibly help explain some of the theta 
variance.  
𝜃𝑗 =  𝛾1(𝑢𝑝𝑡𝑜𝑑𝑎𝑡𝑒)𝑗 + 𝛾2(𝑏𝑐 𝑓𝑎𝑚𝑖𝑙𝑦 ℎ𝑖𝑠𝑡)𝑗 + 𝜀𝑗. (8) 
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We have included a model for theta to possibly explain some of the variance of theta 
where 𝛾1and 𝛾2 are coefficients for up to date and breast cancer family history respectively. The 
residual part of the error 𝜀𝑗 is assumed to be normally distributed with a mean of zero and a 
standard deviation of 1. For identification of model parameters, we set 𝛼10 and 𝛽10 equal to zero, 
this is standard in item response modeling. Table 8 shows the shift in scaling parameters as 
covariates are added into the model. For instance in the 2PL model, parameter a76 was not 
significant, meaning that it did not significantly discriminate theta levels for the sample, however 
in the 2PL model with the covariates up to date and breast cancer family history, when 
accounting for participants being up to date on their mammogram screening and breast cancer 
family history, a76 significantly discriminates breast cancer self-detection knowledge levels for 
the sample (Table 8).  
 
Figure 6. Breast Cancer Self-Detection Knowledge Model 
Note: Dashed lines indicate a non-significant parameter and solid lines indicate significant a parameters 
and covariates. 
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Table 8. Breast Cancer Self-Detection Knowledge Model Comparison  
Breast Cancer Self-Detection Knowledge 
2PL Model 
2PL with covariates up to 
date and bc family history 
Parms Estimates SE p value Estimates SE p value 
 b74 -4.83 0.87 <.0001 -4.25 0.73 <.0001 
 b75 -3.80 0.45 <.0001 -3.37 0.37 <.0001 
 b76 -4.38 1.80 0.0152 -2.73 0.90 0.0026 
 b77 -0.32 0.17 0.0536 0.33 0.22 0.1354 
 a74 2.04 0.62 0.0012 2.03 0.60 0.0007 
 a75 1.23 0.37 0.0009 1.14 0.35 0.0013 
 a76 4.77 2.54 0.0613 4.14 1.79 0.0213 
 a77 1.95 0.47 <.0001 1.76 0.41 <.0001 
up to date       0.73 0.16 <.0001 
bc fam hist       0.05 0.16 0.7379 
 
 The average participant’s breast cancer self-detection knowledge (theta) falls between 
0.09 (Empirical Bayes Estimate [EAP] = -2.43) to 1.84 (EAP=0.61). EAP is the estimated 
random effect (breast cancer self-detection knowledge level) for each participant’s item 
responses in the final model. The item difficulty levels, the b parameter estimates for b74-b76 are 
each negative, meaning that these items are difficult for this sample and b77 was not significant 
meaning that this item did not significantly differentiate difficulty level for the sample. The a 
parameter estimates (1.14-4.14) do discriminate a range of breast cancer self-detection 
knowledge levels for this sample. According to findings, women who are up to date for their 
mammogram are 2.07 times more likely (𝛾1 = 0.73 SE =.02, p <.0001) to have more breast 
cancer self-detection knowledge when compared to those who are not (Table 7).  
Breast cancer other detection knowledge scale 
To fulfill specific aims 3-5 item response models were fit to the breast cancer other 
detection scale items. The likelihood ratio test indicated that the 2PL was a better fitting model 
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when compared to the 1PL, (𝜒2(4) = 21.4, 𝑝 < 0.0001; Table 14). However, the item 
discrimination parameter, a71, (It is possible to have breast cancer without symptoms) in the 2PL 
model was negative meaning that this item failed to discriminate women’s breast cancer other 
detection knowledge and should be revised (Embretson & Reise, 2000). As a result, no further 
analyses were explored with this model. 
 
Figure 7. Breast Cancer Other Detection Knowledge Model  
Note: Dashed lines indicate non-significant a parameter and solid lines indicate significant a parameters. 
The 2PL model estimates the likelihood participants responded correctly (yes). 
According to the equation below, Y is likelihood that person j answered item i correctly (yes), 
given their breast cancer other-detection knowledge level. bj is person j’s breast cancer other-
detection knowledge and ai is discrimination parameter for item i etc… 
2PL Model  
𝑃 (𝑌𝑖𝑗 = 1│𝜃𝑗) =  
𝑒𝑥𝑝⌊𝑎𝑖𝜃𝑗+𝑏𝑖⌋
∑ 𝑒𝑥𝑝⌈𝑎𝑖𝜃𝑗+𝑏𝑖⌉
. (9) 
Significant bi parameters for the scale ranged from -1.00 to 1.99, which indicates that 
items had a limited range in difficulty level for this sample (Table 15). The ai parameters went 
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from 0.48 to 2.50 which indicate that items discriminated a moderate range of participants’ 
breast cancer other-detection knowledge levels for this sample.  
Cervical Cancer Knowledge Scale 
Table 9. Cervical Cancer Knowledge Items 
  Categories 
  No Yes DK 
Item n % N % n % 
99 39 9.5 287 70.0 84 20.5 
100 53 12.9 231 56.3 126 30.7 
101
i
 26 6.3 348 84.9 36 8.8 
102
iii
 58 14.5 323 79.0 28 6.9 
103
i
 27 6.6 371 90.5 12 2.9 
104
iii
 5 1.2 395 96.6 9 2.2 
105 12 2.9 355 86.6 43 10.5 
106 15 3.7 366 89.3 29 7.1 
107 4 1.0 366 89.3 40 9.8 
108 28 6.8 336 82.0 46 11.2 
Note: DK="I don't know." iItem was reverse-scored. iiItem 
had missing data. 
 
According to Table 9, a majority of the participants correctly answered these items. Items 
99, 101, 102, 103, 104, 105, 106, 107, and 108 the “no” and “I don’t know” responses combined 
are about 1/3 or less of responses (or much smaller when compared to “yes” category). Which 
means that “I don’t know” category might not be necessary for some of these items. 
Furthermore, the limited “no” and “I don’t know” responses for some items may mean that these 
items are less difficult than others. 
Cervical cancer Mokken scaling 
To fulfill specific aims 1-2 exploratory Mokken scale analyses were done using 10 
cervical cancer nominal response items (99-108). Two different combinations of item response 
ordering were performed since the latent scaling metric is unknown which are noted by the 
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combination number. Subscales with 3 or less items were not considered for confirmatory 
analyses (Shenkin et al., 2014). 
Combination #1-exploratory analyses 
 Findings indicated that there was one subscale (Pap test knowledge) when responses 
were ordered as “no,” “I don’t know,” “yes.”  Investigations of latent monotonicity (IIO) 
indicated that 3 items (100, 102, 105) were unscalable and had several violations. The overall 
scale had very low scalability (H=0.06) and all item scalability coefficients, H, were below.3. 
The scale had high monotonicity (H
T
=0.74) with no violations of monotonicity. The AISP and 
GA indicated only 1 subscale, Pap test knowledge (items 101, 103, and 104) with only 3 items. 
Therefore, there was no need to examine multidimensionality further in the analyses.  
Combination #2-exploratory analyses 
Findings indicated that there were possibly two subscales when responses were ordered 
as “yes,” “no,” “I don’t know.” The overall scale had low, but adequate scalability (H=0.32) and 
only 3 item scalability coefficients H were below .3. Investigations of latent monotonicity (IIO) 
indicated that 3 items (101, 102, and 105) were unscalable and had several violations. The scale 
had adequate monotonicity (H
T
=0.44) with several violations of monotonicity. The AISP and 
GA indicated only 1 subscale (cervical cancer knowledge). Therefore, there was no need to 
examine multidimensionality further in the analyses.  
Confirmatory analyses 
Confirmatory analyses (Table 10) indicated that the overall scale had acceptable 
scalability (H=0.42) with no item scalability coefficients, H, below.3 (Table 11). Investigations 
of latent monotonicity (IIO) indicated no violations of monotonicity and adequate monotonicity 
(H
T
=0.39). 
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Table 10. Cervical Cancer Knowledge Combination #2 
 
Dimension Algorithm Items H (S.E.) Monotonicity? H
T
 
Cervical cancer 
knowledge 
GA 
99, 100, 103
i
, 
104
i
, 106, 107, 
108 
0.42(.05) Yes 0.39 
Note: 
i
Reverse coded item. 
Table 11. Item Scalability Coefficients for Final Cervical Cancer Knowledge Model 
Cervical Cancer Scale 
 
Item H S.E. 
 
 
99 0.42 0.05 
 
 
100 0.40 0.06 
 
 
103 0.38 0.06 
 
 
104 0.36 0.12 
 
 
106 0.43 0.06 
 
 
107 0.50 0.05 
 
 
108 0.42 0.05 
   Total H 0.42 0.05   
 
Explanatory item response modeling 
Cervical cancer knowledge scale 
To fulfill specific aims 3-5 explanatory item response models were fit to cervical cancer 
knowledge scale items. The likelihood ratio test indicated that the 2PL was a better fitting model 
when compared to the 1PL, (𝜒2(7) = 33.3, 𝑝 < 0.0001; Table 16). The 2PL model with the 
covariates Artigas, Treinta y tres, and up to date was a better fitting model when compared to the 
2PL, (𝜒2(3) = 43.7, 𝑝 < 0.0001). The information criteria indices (AIC= 2136.4, BIC= 2204.6) 
indicated that including the covariates or fixed effects for women who are up to date and being 
from Artigas or Treinta y tres significantly contributed to the cervical cancer knowledge model 
(Table 12; Figure 8). The other models (2PL model with the covariates up to date, cervical 
cancer family history, cancer education; 2PL with the covariates up to date, Artigas, and had 
children; and the 2PL model with the covariates up to date and Artigas) can be found in Table 
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16. When comparing the 2PL model to the 2PL model with the covariates up to date, Artigas, 
and Treinta y tres we can see that the item parameter values shift as covariates are added into the 
model (Table 12). 
The final model estimates the likelihood participants responded correctly. For the final 
model, 𝑃 (𝑌 = 1| 𝜃𝑗𝑎𝑛𝑑 𝑐𝑜𝑣𝑎𝑟𝑖𝑎𝑡𝑒𝑠 𝑢𝑝 𝑡𝑜 𝑑𝑎𝑡𝑒, 𝐴𝑟𝑡𝑖𝑔𝑎𝑠, 𝑎𝑛𝑑 𝑇𝑟𝑒𝑖𝑛𝑡𝑎 𝑦 𝑡𝑟𝑒𝑠) is likelihood 
that person j answered item i correctly (yes), given their over cervical cancer knowledge level. bj 
is person j’s cervical cancer knowledge and ai is the coefficient for “slope” for item i etc… 
2PL Model with covariates up to date, Artigas, and Treinta y tres  
𝑃 (𝑌𝑖𝑗 = 1│𝜃𝑗  𝑎𝑛𝑑 𝑢𝑝 𝑡𝑜 𝑑𝑎𝑡𝑒, 𝐴𝑟𝑡𝑖𝑔𝑎𝑠, 𝑎𝑛𝑑 𝑇𝑟𝑖𝑒𝑛𝑡𝑎 𝑦 𝑡𝑟𝑒𝑠) =  
𝑒𝑥𝑝⌊𝑎𝑖𝜃𝑗+𝑏𝑖⌋
∑ 𝑒𝑥𝑝⌈𝑎𝑖𝜃𝑗+ 𝑏𝑖⌉
. (10) 
According to the equation for 𝜃𝑗  below adding in the covariates, up to date, Artigas, and Treinta 
y tres (𝛾1 − 𝛾3) given items i through p (𝛾𝑖𝑗 … 𝛾𝑝𝑗) into the model helps explain some of the 
theta (cervical cancer knowledge) variance.  
 𝜃𝑗 =  𝛾1(𝑢𝑝 𝑡𝑜 𝑑𝑎𝑡𝑒)𝑗 + 𝛾2(𝐴𝑟𝑡𝑖𝑔𝑎𝑠)𝑗 + 𝛾3(𝑇𝑟𝑒𝑖𝑛𝑡𝑎 𝑦 𝑡𝑟𝑒𝑠)𝑗 + 𝜀𝑗. (11) 
We have included a model for theta to possibly explain some of the variance of theta 
where 𝛾1- 𝛾3 are coefficients for up to date, Artigas, and Treinta y tres respectively. The residual 
part of the error 𝜀𝑗 is assumed to be normally distributed with a mean of zero and a standard 
deviation of 1. For identification of model parameters, we set 𝛼10 and 𝛽10 equal to zero which is 
standard in IRT.  
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Figure 8. Cervical Cancer Knowledge Final Model 
Note: Dashed lines indicate non-significant covariates and black lines indicate significant a parameters 
and covariates. 
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Table 12. Cervical Cancer Knowledge Model Comparisons 
Cervical Cancer Knowledge 
2PL 
2PL with covariates up to 
date, Artigas and Trienta y 
tres 
Parms Estimates SE p value Estimates SE p value 
b99 -1.09 0.16 <.0001  -0.38 0.18 0.0332 
 b100 -0.28 0.11 0.0123 0.20 0.16 0.2188 
 b103 -2.92 0.31 <.0001  -2.22 0.26 <.0001 
 b104 -4.07 0.50 <.0001  -3.39 0.37 <.0001 
 b106 -3.24 0.40 <.0001  -2.27 0.33 <.0001 
 b107 -6.75 2.57 0.009 -2.90 0.62 <.0001 
 b108 -2.37 0.30 <.0001  -1.24 0.20 <.0001 
a99 1.28 0.24 <.0001  1.17 0.22 <.0001 
 a100 0.79 0.18 <.0001  0.79 0.16 <.0001 
 a103 1.40 0.29 <.0001  1.40 0.28 <.0001 
 a104 1.29 0.38 0.0009 1.18 0.34 0.0006 
 a106 1.96 0.37 <.0001  1.94 0.40 <.0001 
a107 5.03 1.87 0.0076 3.09 0.80 0.0001 
a108 1.98 0.37 <.0001  1.33 0.26 <.0001 
up to date       0.81 0.16 <.0001 
Artigas        0.79 0.21 0.0002 
Treinta y tres       0.28 0.18 0.1326 
 
All ai parameters for the items significantly discriminated theta levels. All the bi 
parameters except b100 (A symptom of cervical cancer is bleeding when a woman is not having 
her period) significantly estimated item difficulty levels for the sample. The average participant’s 
cervical cancer knowledge (theta) falls between 0.10 (Empirical Bayes Estimate [EAP] = -2.29) 
to 2.22 (EAP=0.80). EAP is the estimated random effect (cervical cancer knowledge level) for 
each participant on item responses in the final model. All significant b parameters are negative 
which means that these items are relatively difficult for this sample. Yet, when comparing b 
parameter estimates in the 2PL model with covariates for Treinta y tres, Artigas, and up to date 
to the 2PL model, the bi parameters do become slightly larger when the covariates up to date, 
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Treinta y tres and Artigas are added into the model, meaning that the knowledge items improve 
in differentiating knowledge levels when accounting for these fixed effects. Several ai parameters 
fall between 0-1.5 (e.g., a99, a100, a103, a104, a108), which means that they are not very 
discriminating in terms of differentiating participants’ cervical cancer knowledge levels for this 
sample. According to findings, women who are up to date for their Pap test are 2.26 times 
(𝛾1 = 0.81, SE =.02, p <.0001) more likely to have higher cervical cancer knowledge scores 
when compared to those who are not (Table 12). Artigas residents are 2.20 times (𝛾1 = 0.80, SE 
=.02, p<.001) more likely to have higher cervical cancer knowledge scores compared to women 
in other areas. Treinta y tres (𝛾3 = −0.28, SE =.02, p =.13) residents did not have significantly 
different cervical cancer knowledge scores when compared to women in other areas. 
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CHAPTER 5 
DISCUSSION 
Overview 
This study provides a unique contribution to breast and cervical cancer health field by: (a) 
bringing to light factors influencing screening in Uruguayan women, (b) building the knowledge 
base about cultural and conceptual knowledge, and (c) contributing to the area of health literacy 
measurement. In this section, primary findings related to the project’s specific aims are 
highlighted. These findings are then connected to recent health literacy literature, cancer 
promotion implications, and the scaling literature. Following that section are study limitations, 
suggestions for future research, and a conclusion. 
Knowledge Scale Findings 
 Breast and cervical cancer knowledge items consisted of three Mokken scales: (a) breast 
cancer self-detection, (b) breast cancer other detection, and (c) cervical cancer knowledge scales 
after 7 unscalable items (72, 79, 81, 82, 101, 102, 105) were removed. IRT analyses indicated 
that each remaining item significantly contributed to the overall models, except for the a 
parameter for item 71 in the breast cancer other detection scale. Item parameter estimates for 
breast cancer self-detection and cervical cancer knowledge were further refined by adding 
participant characteristics into the model, which also significantly contributed to the model and 
the latent variable for each scale. Findings indicated that women who were up to date for a 
mammogram reported higher levels of knowledge about breast cancer self-detection than those 
who were not up to date. Likewise, women who were up to date for a Pap test and resided in 
Artigas reported more cervical cancer knowledge than those who were not up to date and resided 
in other areas.  
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Health Literacy 
 There is a strong connection between health literacy and breast and cervical cancer 
screening which has implications for health education and clinical settings (Lindau, Tomori, 
McCarville, & Bennett, 2001). Health literacy plays an important role in identifying cancer 
symptoms, obtaining regular screenings, and seeking medical advice (Jordan, Buchbinder, & 
Osborne, 2010). Breast and cervical cancer knowledge is a critical element of cancer promotion 
as this can improve women’s abilities to detect and prevent cancer. The connection between 
health literacy and health is a strong one found in the literature; therefore measuring this has 
implications for screening behaviors as well as clinical and health education settings Our 
findings indicated that women who had regular cancer screenings had more breast cancer self-
detection knowledge and cervical cancer knowledge. These findings demonstrate that knowledge 
is an essential component of health literacy to measure and consider in health care and education 
settings. These findings also help to build the cultural and conceptual knowledge literature and 
test specific health literacy theories for future research. 
Implications for Health Literacy Theory 
 Study findings help move the field of health literacy forward by providing a tool for 
testing and building cultural and conceptual knowledge. Measures such as the CLM-BCC can be 
used to further develop health literacy theory (Pleasant et al., 2011). Researchers can use CLM-
BCC knowledge scales to test health literacy theories that include cultural conceptual 
knowledge. By testing health literacy, this theory can be evaluated and refined to help determine 
how breast and cervical cancer knowledge and other factors (e.g, attitudes, beliefs, emotions) 
influence screening outcomes. 
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Participants’ Characteristics 
 Study findings indicate the utility and benefit of IRT methods. Findings indicated three 
Mokken scales with items measuring breast and cervical cancer knowledge. EIRM was used to 
assess the fit of the breast cancer self-detection and cervical cancer knowledge models. The 
breast cancer other detection knowledge scale had an item with a non-discriminating ai 
parameter, therefore no covariates were added into the model. When participants’ characteristics 
were added as covariates into the IRT model, findings indicated significant differences in 
women’s breast cancer self-detection knowledge and cervical cancer knowledge levels. These 
findings suggest that participant characteristics are important to consider for health education and 
cancer promotion. EIRM goes beyond traditional IRT to explain the associations between survey 
items and participants’ characteristics in this study. By taking an explanatory approach we 
increased our understanding of the sample and this measure.  
Breast Cancer Knowledge 
As noted in the literature, women with higher breast cancer self-detection knowledge are 
more likely to obtain a timely mammogram screening, which is consistent by our study findings 
(Buki et al., 2007; Graves et al., 2008). Similar to our findings, Bird and colleagues (2010) found 
no difference in women’s breast cancer other detection knowledge levels for those with a family 
history of breast cancer. A unique finding in our study is that the breast cancer knowledge 
consisted of two dimensions: breast cancer self-detection and breast cancer other detection 
knowledge. However, there is evidence of a few multidimensional breast cancer knowledge 
scales in the literature, yet few measures have been developed beyond classical test theory and 
factor analysis at this time (McCance, Mooney, Smith, & Fields, 1990; Stager, 1993). IRT allows 
us to examine item-level properties unlike these other approaches. 
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Cervical Cancer Knowledge 
Women who resided in Artigas had significantly higher cervical cancer knowledge 
scores. The province with the highest distribution of new cases, Treinta y tres, did not have a 
significant effect. However, based on country statistics the province of Artigas did have the 
second highest distribution of new cervical cancer cases (19.61%) in our sample. In the present 
study, women from Artigas had a slightly higher mean formal education level (M=11.42, 
SD=3.84) than the sample (M=10.43, SD=4.32), which might explain why women in this area 
had higher knowledge scores. These findings are echoed in the U.S. literature; Ramirez and 
colleagues (2000) found that Hispanic women with high formal education levels had high 
knowledge of Pap screening guidelines, and were more likely to be up to date for their Pap test. 
This finding is consistent with the connection between cervical cancer knowledge and screening.  
Cancer Promotion Implications 
Implications for health educators and clinicians 
  Findings indicate that health education that aims at building health literacy for adults 
should be tailored to the target population (Nutbeam, 2008). We recommend a person-centered 
or tailored approach focusing on building women’s breast cancer self-detection and cervical 
cancer knowledge to increase screening behavior (Nutbeam, 2008). In terms of this study’s 
relevance to breast and cervical cancer promotion in Uruguay, our findings highlight that 
knowledge pertaining to breast and cervical cancer is associated with screening behavior. This is 
an important relationship to build upon in a health education and clinical setting. Likewise, 
cancer educators and clinicians must understand that larger structural forces such as geographic 
location can influence cervical cancer knowledge. The literature indicates that geographic 
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location can influence opportunities for further health education and knowledge (e.g., living a 
community with regular cancer promotion workshops; Buki, Montoya, & Linares, 2013).  
 Implications for CHLCC 
 Despite the fact that Uruguayan women have free biannual screenings and universal 
healthcare, women are still underscreened. The only screening data available indicates that too 
many women in Uruguay are being diagnosed at stage III (16.6%; Justo et al., 2013; Krygier et 
al., 2007). Therefore, the need for cancer promotion is timely and imperative. Findings such as 
these are pressing as Uruguay considers removing mandatory federally funded mammography 
programs based on recent systematic reviews indicating that the risks associated with this 
approach and the over diagnosis of breast cancer outweighs the risk of early detection 
(Jørgensen, 2013; Thorton, 2014; Gøtsche & Jørgensen, 2013). A recent petition was created by 
a Uruguayan woman online asking the government to remove the federal mandate that all 
women ages 40-59 years be screened every other year in order to work (see 
https://secure.avaaz.org/es/petition/MAMOGRAFIA_OBLIGATORIA_EN_URUGUAY_UN_P
ROBLEMA_CIENTIFICO_Y_UN_ABUSO_ETICO/). This petition is based on the premise that 
Uruguayan women are not able to consent to screening, but are instead required (Thorton, 2014). 
This federal mandate leads women to face increased radiation exposure which may increase 
women’s risk for breast cancer (Gøtsche & Jørgensen, 2013; Jørgensen, 2013). Although the 
mammogram’s use may be debatable, there is still a need for ongoing cervical cancer education 
to reduce incidence and mortality rates in Uruguay. 
Scaling Recommendations 
At this time, there is a dearth of breast and cervical cancer knowledge scales. These 
scales have not been rigorously tested using item response or explanatory item response 
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modeling. Therefore, our findings cannot be compared to other scales. The two extant breast 
cancer knowledge scales in the literature have been created using classical test theory and factor 
analytic approaches and use “no,” “yes,” and “I don’t know” or “agree/disagree” response 
options (Stager, 1993; Ondrusek et al., 1999). The literature is mixed on where “don’t know” 
responses lie on the latent metric and the scoring rule for responses. A study using political 
opinions indicated that “don’t know” responses fell in between “yes” and “no” responses 
(Groothuis & Whitehead, 2002). However, a study by Anderson, Verkuilen, and Peyton (2010), 
found that “don’t know” responses were treated by participants similarly to a guessing parameter 
on political opinion survey. Given these issues and the desire to use this scale in a lay health 
education and clinical setting, it would be beneficial to explore other response options in the 
future. One suggestion is to create two categories to replace “don’t know” with “maybe yes” and 
“maybe no” responses. Researchers could examine the latent scaling metric for these responses 
and compare them to “don’t know,” “yes,” and “no” responses. 
Krosnick and Presser (2010) noted that using no/yes questions may lead to participant 
acquiescence and should be avoided in surveys. Furthermore, a yes/no format can be less valid 
and reliable than answering the same questions in a different format such as a multiple choice 
(Krosnick & Presser, 2010; Isard, 1956; Eurich, 1931; Watson & Crawford, 1930). Multiple 
choice response options may help discriminate women’s knowledge levels better and increase 
the range of difficulty. 
In terms of current knowledge items, some subscales would benefit from adding more 
items that capture a broader range of the latent variable. Item 71 (It is possible to have breast 
cancer without symptoms) on the breast cancer other detection knowledge scale, which had a 
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negative ai parameter, could benefit from being revised. Based on Figure 9, the breast cancer 
self-detection knowledge scale captures only individuals whose latent trait ranges from 0-2.  
 
Figure 9. Breast Cancer Self-Detection Knowledge Theta Levels 
Most individuals’ cervical cancer theta levels fell between 0 -2 (figure 10); therefore, the scale 
could be strengthened by adding in more items that capture a wider range of theta (lower and 
higher). 
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Figure 10.Cervical Cancer Knowledge Theta Levels 
Limitations 
This study has potential weaknesses that should be considered. Convenience sampling 
was used instead of a random sampling strategy. Also, participants were selected based on their 
screening status, which requires that findings be interpreted with caution because this increases 
the effects of screening in our data (Hubbard & Lin, 2011). Furthermore, women were not 
sampled from all provinces in Uruguay; therefore we cannot infer that province-based findings 
generalize to other locations. Likewise, women were sampled in only 1 city from each province; 
therefore, we do not know the specific barriers or structural forces influencing other Uruguayan 
women’s environment and health. The data for this study were cross-sectional; therefore we are 
only viewing a snapshot of women’s cancer screening context.  
Future Research Recommendations 
We recommend that health measurement researchers employ IRT when developing new 
cancer knowledge scales. Given the limited literature on cancer knowledge scales, this area 
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would be strengthened by further examination. A study exploring current breast and cervical 
cancer knowledge measures will help move the field of measurement development forward. 
Furthermore, more research examining the dimensionality of breast and cervical knowledge 
domains as well as item-level properties of cancer knowledge items (difficulty, discrimination) 
will help move this area of the field forward and improve measurement rigor. In terms of cancer 
education and study findings in Uruguay, we recommend that researchers examine women’s 
health education contexts in depth using qualitative and quantitative methods to understand 
processes influencing cancer knowledge and identify the best contexts and modes for breast and 
cervical cancer education. Longitudinal analyses could be used to explore this further in-depth 
and over time.  
Conclusion 
Our study indicated that the CLM-BCC breast and cervical cancer knowledge items 
yielded three Mokken scales: (a) breast cancer self-detection knowledge, (b) breast cancer other 
detection knowledge, and (c) cervical cancer knowledge. Taking an explanatory approach, 
women who were up to date with their mammograms were more knowledgeable in breast cancer 
self-detection. Women who lived in Artigas and were up to date with their Pap test had more 
cervical cancer knowledge. Overall, this study demonstrates the benefits of IRT for scale 
validation and development. The CLM-BCC holds promise for assessing breast and cervical 
cancer knowledge and developing cancer education programs in Uruguay. Our study provides 
evidence that there is a direct link between screening status and knowledge levels for breast and 
cervical cancer. Furthermore, individual-level factors are important to consider when assessing 
women’s cancer knowledge and developing health education person-centered approaches. Our 
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findings have practical implications for future health measurement research, health education 
settings, and testing health literacy theory.  
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Table 13 
Knowledge Scale Items. 
  
Item
74
75
76
77
Item
71
73
78
80
Item
99
100
103
104
106
107
108
Regular Pap smears help prevent one from dying of cervical cancer.
A Pap smear is used to detect cervical cancer.
A Pap smear is done to see if there is a growing tumor in the cervix.
A symptom of cervical cancer is bleeding when a woman is not having her 
period.
A woman should get a Pap smear only when she has a gynecological 
(feminine) problem.
A woman should get a Pap smear only when she is pregnant.
Breast Cancer Other Detection Knowledge
Cervical Cancer Knowledge
It is possible to have cervical cancer without symptoms.
It is possible to have breast cancer without symptoms.
A symptom of breast cancer is a change in the texture of the skin of the 
breast.
A woman needs to have a mammogram only when something is wrong 
with her breast.
A mammogram can find a small breast cancer lump before my health care 
provider or I can find it.
A woman can massage the breast to find out if there is a hard lump.
The earlier a cancer is detected, the better the chances for survival.
As part of a breast self-exam, a woman looks at her breasts in the mirror.
As part of a breast self-exam, a woman squeezes her nipples.
Breast Cancer Self-Detection Knowledge
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Table 14 
EIRM Breast Cancer Self-Detection Knowledge Scale Parameter Estimates. 
Model Parameter Estimate S.E. P-value Gradient -2 LL' AIC BIC 
A           1127.5 1137.5 1157.6 
   b74 -5.07 0.44  <.0001 -0.00047       
   b75 -4.99 0.43  <.0001 0.000465       
   b76 -2.51 0.26  <.0001 -0.00037       
   b77 -0.34 0.18 0.058 0.000498       
   Std 2.25 0.25  <.0001 0.000151       
B           1117.7 1133.7 1165.8 
   b74 -4.83 0.87 <.0001 -1.72E-06       
   b75 -3.80 0.45 <.0001 -2.44E-06       
   b76 -4.38 1.80 0.0152 1.75E-06       
   b77 -0.32 0.17 0.0536 -1.33E-06       
   a74 2.04 0.62 0.0012 -2.28E-06       
   a75 1.23 0.37 0.0009 -3.94E-06       
   a76 4.77 2.54 0.0613 1.18E-06       
   a77 1.95 0.47 <.0001 -1.84E-06       
C           1041.2 1063.2 1107.1 
  b74  -4.11 0.71 <.0001 -1.09E-06       
  b75  -3.28 0.35 <.0001 -5.01E-07       
  b76  -2.45 0.79 0.002 2.02E-06       
  b77  0.46 0.24 0.0597 -2.79E-06       
  a74  2.01 0.60 0.0008 -2.69E-07       
  a75  1.11 0.35 0.0016 -4.02E-08       
  a76  4.09 1.68 0.0153 6.27E-07       
  a77  1.80 0.41 <.0001 -1.79E-07       
  up to date 0.67 0.16 <.0001 -2.16E-06       
  bc fam hist 0.08 0.17 0.6293 -1.41E-06       
  cancer educ 0.22 0.16 0.1742 -2.68E-06       
D           1092.1 1112.1 1152.3 
  b74 -4.31 0.75  <.0001 2.13E-06       
  b75 -3.42 0.38  <.0001 3.22E-06       
  b76 -2.58 0.65  <.0001 -2.20E-06       
  b77 0.31 0.22 0.1724 2.35E-06       
  a74 2.03 0.59 0.0007 1.85E-06       
  a75 1.18 0.35 0.0009 4.41E-06       
  a76 3.70 1.17 0.0017 -8.06E-07       
  a77 1.82 0.42  <.0001 6.82E-07       
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Table 14 (cont.) 
Model Parameter Estimate S.E. P-value Gradient -2 LL' AIC BIC 
  up to date 0.72 0.15  <.0001 -3.32E-06       
  montevideo -0.17 0.18 0.3399 4.14E-06       
E           1056 1078 1122.2 
  b74  -3.64 0.61  <.0001 -6.66E-07       
  b75  -3.01 0.34  <.0001 -1.17E-06       
  b76  -1.17 0.73 0.1098 5.85E-07       
  b77  0.96 0.34 0.0046 -7.51E-07       
  a74  2.00 0.54 0.0003 -1.54E-06       
  a75  1.17 0.32 0.0003 -1.73E-06       
  a76  3.70 1.39 0.0082 -5.91E-08       
  a77  1.61 0.31 <.0001 2.09E-07       
  up to date 0.56 0.16 0.0003 -5.30E-06       
  maldonado -0.58 0.17 0.0009 6.48E-06       
  
self breast 
exam 
0.76 0.18 <.0001 3.57E-06       
F           1045 1065 1104.9 
  b74 -4.25 0.73 <.0001 1.11E-06       
  b75 -3.37 0.37 <.0001 1.55E-06       
  b76 -2.73 0.90 0.0026 1.82E-06       
  b77 0.33 0.22 0.1354 -3.27E-06       
  a74 2.03 0.60 0.0007 1.12E-06       
  a75 1.14 0.35 0.0013 2.74E-06       
  a76 4.14 1.79 0.0213 1.49E-06       
  a77 1.76 0.41 <.0001 1.40E-06       
  up to date 0.73 0.16 <.0001 -2.75E-06       
  bc fam hist 0.05 0.16 0.7379 -1.27E-06       
G           1093 1111 1147.2 
  b74 -4.17 0.69 <.0001 -1.16E-07       
  b75 -3.36 0.36 <.0001 6.70E-07       
  b76 -2.65 0.86 0.0022 -6.01E-07       
  b77 0.37 0.21 0.0738 4.17E-07       
  a74 1.99 0.57 0.0005 1.37E-07       
  a75 1.17 0.35 0.0008 -3.82E-07       
  a76 4.24 1.77 0.0173 -1.74E-07       
  a77 1.73 0.38 <.0001 -3.07E-08       
  up to date 0.74 0.16 <.0001 1.76E-06       
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Table 15 
Additional Breast Cancer Self-Detection Knowledge Scale Estimates. 
Model Parameter Estimate S.E. P-value 
A var(theta) 5.07 1.12  <.0001 
B a74/b74 -0.42 0.07  <.0001 
  a75/b75 -0.32 0.07  <.0001 
  a76/b76 -1.09 0.19  <.0001 
  a77/b77 -6.00 3.11 0.0546 
C a74/b74 -0.49 0.09  <.0001 
  a75/b75 -0.34 0.09 0.0002 
  a76/b76 -1.67 0.39  <.0001 
  a77/b77 3.89 1.91 0.0423 
  up to date 1.96 0.32 <.0001 
D a74/b74 -0.47 0.08  <.0001 
  a75/b75 -0.34 0.08  <.0001 
  a76/b76 -1.43 0.28  <.0001 
  a77/b77 5.95 4.29 0.1667 
  up to date 2.05 0.31  <.0001 
E a74/b74 -0.55 0.11 <.0001 
  a75/b75 -0.39 0.10 <.0001 
  a76/b76 -3.15 1.64 0.0552 
  a77/b77 1.67 0.51 0.0013 
  up to date 1.76 0.27 <.0001 
  Maldonado 0.56 0.10 <.0001 
  self-breast exam 2.14 0.38 <.0001 
F a74/b74 -0.48 0.08 <.0001 
  a75/b75 -0.34 0.09 0.0001 
  a76/b76 -1.51 0.32 <.0001 
  a77/b77 5.28 3.40 0.1214 
  up to date 2.07 0.32 <.0001 
G a74/b74 -0.48 0.08 <.0001 
  a75/b75 -0.35 0.08 <.0001 
  a76/b76 -1.60 0.31  <.0001 
  a77/b77 4.65 2.48 0.0613 
  up to date 2.10 0.33 <.0001 
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Table 16 
IRT Breast Cancer Other Detection Knowledge Subscale Parameter Estimates. 
Model Parameter Estimate S.E. P-value Gradient -2 LL' AIC BIC 
A 
     
1504.5 1514.5 1534.6 
 
b71  -1.42 0.16  <.0001 0.000018 
   
 
b73  -0.90 0.14  <.0001 -5.78E-06 
   
 
b78  2.58 0.21  <.0001 -5.90E-06 
   
 
b80  2.73 0.22  <.0001 -0.00002 
   
  std  1.34 0.14  <.0001 0.000048       
B 
     
1483.1 1499.1 1531.2 
 
b71  -1.47 0.21  <.0001 -2.05E-07 
   
 
b73  -0.70 0.11  <.0001 -1.46E-07 
   
 
b78  3.61 0.78  <.0001 5.82E-08 
   
 
b80  3.49 0.64  <.0001 -7.81E-08 
   
 
a71  -1.44 0.33  <.0001 1.72E-07 
   
 
a73  0.48 0.19 0.0107 -1.81E-07 
   
 
a78  2.50 0.75 0.0009 -7.49E-08 
   
  a80  2.18 0.60 0.0003 7.67E-08       
 
Table 17 
Additional Breast Cancer Other Detection Knowledge Subscale Estimates. 
Model Parameter Estimate S.E. P-value 
A var(theta) 1.80 0.39 <.0001 
B a71/b71 0.98 0.16 <.0001 
  a73/b73 -0.68 0.26 0.0099 
  a78/b78 0.69 0.08 <.0001 
  a80/b80 0.63 0.08 <.0001 
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Table 18 
EIRM Cervical Cancer Knowledge Subscale Parameter Estimates.  
Model Parameter Estimate S.E. P-value Gradient -2 LL' AIC BIC 
A           2179.4 2195.4 2227.6 
  b99   -1.17 0.15 <.0001  0.000543       
  b100  -0.34 0.14 0.0152 -0.00013       
  b103  -3.04 0.22 <.0001  1.05E-04       
  b104  -4.36 0.33 <.0001  0.000059       
  b106  -2.87 0.21 <.0001  1.10E-04       
  b107  -2.87 0.21 <.0001  1.10E-04       
  b108  -2.08 0.18 <.0001  -2.40E-04       
  std   1.51 0.12 <.0001  4.93E-04       
B           2146.1 2174.1 2230.3 
   b99  -1.09 0.16 <.0001  -9.25E-07       
   b100 -0.28 0.11 0.0123 -3.66E-07       
   b103 -2.92 0.31 <.0001  -1.64E-07       
   b104 -4.07 0.50 <.0001  3.05E-08       
   b106 -3.24 0.40 <.0001  -4.77E-07       
   b107 -6.75 2.57 0.009 8.84E-08       
   b108 -2.37 0.30 <.0001  1.01E-07       
   a99  1.28 0.24 <.0001  -9.92E-07       
   a100 0.79 0.18 <.0001  8.70E-07       
   a103 1.40 0.29 <.0001  -2.22E-07       
   a104 1.29 0.38 0.0009 -2.34E-07       
   a106 1.96 0.37 <.0001  -8.72E-07       
  a107 5.03 1.87 0.0076 8.33E-08       
  a108 1.98 0.37 <.0001  -1.16E-08       
C           1987.3 2021.3 2088.8 
  b99    -1.80 0.27 <.0001  6.26E-06       
  b100   -0.79 0.18 <.0001  1.10E-05       
  b103   -4.02 0.58 <.0001  1.40E-05       
  b104   -4.72 0.69 <.0001  1.40E-05       
  b106   -4.51 0.70 <.0001  -4.00E-05       
  b107   -7.49 2.04 0.0003 2.06E-07       
  b108   -2.84 0.38 <.0001  -2.00E-05       
  a99    1.15 0.23 <.0001  1.50E-05       
  a100   0.77 0.17 <.0001  3.30E-05       
  a103   1.50 0.32 <.0001  1.90E-05       
  a104   1.16 0.37 0.0016 2.90E-05       
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Table 18 (cont.) 
Model Parameter Estimate S.E. P-value Gradient -2 LL' AIC BIC 
  b106   -4.51 0.70 <.0001  -4.00E-05       
  b107   -7.49 2.04 0.0003 2.06E-07       
  b108   -2.84 0.38 <.0001  -2.00E-05       
  a99    1.15 0.23 <.0001  1.50E-05       
  a100   0.77 0.17 <.0001  3.30E-05       
  a103   1.50 0.32 <.0001  1.90E-05       
  a104   1.16 0.37 0.0016 2.90E-05       
  a106   1.89 0.40 <.0001  -6.00E-05       
  a107   3.61 1.13 0.0015 -4.57E-06       
  a108   1.35 0.29 <.0001  -3.00E-05       
  up to date -0.71 0.16 <.0001  7.50E-05       
  cc fam hist -0.01 0.24 0.9654 -6.13E-06       
  cancer educ -0.36 0.16 0.0246 7.40E-05       
D           2104.5 2138.5 2206.8 
  b99 -0.35 0.33 0.287 -4.00E-05       
  b100 0.20 0.23 0.3846 3.80E-05       
  b103 -2.18 0.41 <.0001 8.67E-06       
  b104 -3.38 0.47 <.0001 -8.77E-06       
  b106 -2.22 0.54 <.0001 1.80E-05       
  b107 -2.80 0.93 0.0026 6.34E-07       
  b108 -1.21 0.37 0.0011 3.48E-06       
  a99 1.19 0.22 <.0001 2.30E-05       
  a100 0.76 0.16 <.0001 -2.00E-05       
  a103 1.41 0.28 <.0001 6.41E-06       
  a104 1.22 0.35 0.0005 -8.70E-06       
  a106 1.93 0.40 <.0001 8.38E-06       
  a107 3.04 0.78 0.0001 -7.81E-07       
  a108 1.34 0.27 <.0001 8.21E-06       
  up to date 0.83 0.16 <.0001 -2.00E-05       
  artigas  0.72 0.21 0.0008 -3.10E-06       
  children 0.10 0.26 0.6881 -3.00E-05       
E           2102.4 2136.4 2204.6 
   b99    -0.38 0.18 0.0332 2.60E-05       
   b100   0.20 0.16 0.2188 -8.39E-06       
   b103   -2.22 0.26 <.0001 0.000015       
   b104   -3.39 0.37 <.0001 -3.46E-06       
   b106   -2.27 0.33 <.0001 -0.00002       
   b107   -2.90 0.62 <.0001 1.30E-06       
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Table 18 (cont.) 
Model Parameter Estimate S.E. P-value Gradient -2 LL' AIC BIC 
   b108   -1.24 0.20 <.0001 -1.00E-05       
   a99    1.17 0.22 <.0001 -0.00001       
   a100   0.79 0.16 <.0001 7.54E-06       
   a103   1.40 0.28 <.0001 0.000014       
   a104   1.18 0.34 0.0006 -5.51E-06       
   a106   1.94 0.40 <.0001 -9.16E-06       
   a107   3.09 0.80 0.0001 1.85E-06       
   a108   1.33 0.26 <.0001 3.30E-06       
  up to date 0.81 0.16 <.0001 -1.00E-05       
  artigas  0.79 0.21 0.0002 0.000011       
  treinta y tres 0.28 0.18 0.1326 1.97E-06       
F           2104.7 2136.7 2200.9 
   b99   -0.46 0.17 0.0075 2.49E-06       
   b100  0.13 0.15 0.3724 -2.18E-06       
   b103  -2.32 0.26 <.0001 3.12E-06       
   b104  -3.50 0.39 <.0001 -1.32E-06       
   b106  -2.40 0.33 <.0001 -5.50E-06       
   b107  -3.08 0.66 <.0001 -3.82E-06       
   b108  -1.33 0.20 <.0001 -1.75E-07       
   a99   1.19 0.23 <.0001 -4.23E-07       
   a100  0.76 0.16 <.0001 -2.72E-06       
   a103  1.41 0.28 <.0001 2.07E-06       
   a104  1.23 0.35 0.0005 -7.08E-06       
   a106  1.93 0.40 <.0001 -1.30E-06       
   a107  3.04 0.80 0.0002 -2.43E-06       
   a108  1.33 0.27 <.0001 -3.64E-06       
  up to date 0.72 0.21 0.0006 0.000011       
  artigas  0.83 0.16 <.0001 1.43E-06       
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Table 19 
Additional Cervical Cancer Knowledge EIRM Estimates. 
Model Parameter Estimate S.E. P-value 
A var(theta) 2.29 0.35 <.0001 
B a99/b99 -1.17 0.20 <.0001 
  a100/b100 -2.77 1.21 0.0224 
  a103/b103 -0.48 0.07 <.0001 
  a104/b104 -0.32 0.07 <.0001 
  a106/b106 -0.61 0.07 <.0001 
  a107/b107 -0.75 0.05 <.0001 
  a108/b108 -0.84 0.10 <.0001 
C a99/b99 -0.64 0.09  <.0001 
  a100/b100 -0.97 0.20  <.0001 
  a103/b103 -0.37 0.04  <.0001 
  a104/b104 -0.25 0.05  <.0001 
  a106/b106 -0.42 0.05  <.0001 
  a107/b107 -0.48 0.05  <.0001 
  a108/b108 -0.48 0.07  <.0001 
  up to date 0.49 0.08  <.0001 
D a99/b99 -3.41 3.33 0.3053 
  a100/b100 3.77 4.17 0.3666 
  a103/b103 -0.64 0.15 <.0001 
  a104/b104 -0.36 0.09 <.0001 
  a106/b106 -0.87 0.24 0.0002 
  a107/b107 -1.09 0.32 0.0008 
  a108/b108 -1.11 0.39 0.0046 
  up to date 2.29 0.36 <.0001 
  Artigas 2.05 0.43 <.0001 
E a99/b99 -3.08 1.66 0.0641 
  a100/b100 3.98 2.91 0.1716 
  a103/b103 -0.63 0.12 <.0001 
  a104/b104 -0.35 0.09 <.0001 
  a106/b106 -0.85 0.15 <.0001 
  a107/b107 -1.06 0.18 <.0001 
  a108/b108 -1.07 0.25 <.0001 
  up to date 2.26 0.36 <.0001 
  Artigas 2.21 0.47 <.0001 
F a99/b99 -2.60 1.15 0.0244 
  a100/b100 5.78 6.03 0.3381 
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Table 19 (cont.) 
Model Parameter Estimate S.E. P-value 
  a103/b103 -0.61 0.11 <.0001 
  a104/b104 -0.35 0.08 <.0001 
  a106/b106 -0.80 0.13 <.0001 
  a107/b107 -0.99 0.15 <.0001 
  a108/b108 -1.00 0.21 <.0001 
  up to date 2.05 0.43 <.0001 
  artigas 2.28 0.36 <.0001 
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APPENDIX A: MAP OF URUGUAY 
 
Note: Starred Provinces are where data were collected. 
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APPENDIX B: CANCER HEALTH LITERACY MEASURE-BREAST AND CERVICAL CANCER-URUGUAY KNOWLEDGE ITEMS-
ENGLISH VERSION 
 
This is the English version of the knowledge items used during data collection in Uruguay (Buki, Reich, & Yee, 2011a). 
For the following questions please, answer “Yes,” “No,” or “I don’t know.”  
71. It is possible to have breast cancer without symptoms  Yes  No  I don’t know 
72. A mass found in the breast is a definite sign of cancer  Yes  No  I don’t know 
73. A symptom of breast cancer is a change in the texture of the 
skin of the breast 
 Yes  No  I don’t know 
74. A woman can massage the breast to find out if there is a hard 
lump 
 Yes  No  I don’t know 
75. The earlier a cancer is detected, the better the chances for 
survival 
 Yes  No  I don’t know 
76. As part of a breast self-exam, a woman looks at her breasts in 
the mirror 
 
 Yes  No  I don’t know 
77. As part of a breast self-exam, a woman squeezes her nipples  Yes  No  I don’t know 
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78. A woman needs to have a mammogram only when something 
is wrong with her breast 
 Yes  No  I don’t know 
79. A mammogram is an x-ray of the breast  Yes  No  I don’t know 
80. A mammogram can find a small breast cancer lump before my 
health care provider or I can find it      
 Yes  No  I don’t know 
81. A mammogram is done to see if there is a growing tumor in the 
breast 
 Yes  No  I don’t know 
82. Younger women have a higher risk of getting breast cancer 
than older women 
 Yes  No  I don’t know 
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For the following questions please, answer “Yes,” “No,” or “I don’t know.”  
99. It is possible to have cervical cancer without symptoms  Yes  No  I don’t know 
100. A symptom of cervical cancer is bleeding when a woman is 
not having her period 
 Yes  No  I don’t know 
101. A woman should have a Pap smear only after she has 
children 
 Yes  No  I don’t know 
102. A woman needs to have a Pap smear only when she is 
sexually active 
 Yes  No  I don’t know 
103. A woman should get a Pap smear only when she has a 
gynecological (feminine) problem 
 Yes  No  I don’t know 
104. A woman should get a Pap smear only when she is pregnant  Yes  No  I don’t know 
105. A woman who is past menopause should get a Pap smear  Yes  No  I don’t know 
106. Regular Pap smears help prevent one from dying of cervical 
cancer  
 Yes  No  I don’t know 
107. A Pap smear is used to detect cervical cancer  Yes  No  I don’t know 
108. A Pap smear is done to see if there is a growing tumor in the 
cervix 
 Yes  No  I don’t know 
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APPENDIX C: CANCER HEALTH LITERACY MEASURE-BREAST AND CERVICAL CANCER-URUGUAY KNOWLEDGE 
ITEMS-SPANISH VERSION 
 
This is the Spanish version of the knowledge items used during data collection in Uruguay (Buki, Reich, & Yee, 2011a). 
Para las siguientes afirmaciones, por favor responda “sí”, “no”, o “no sé”. 
71. Es posible tener cáncer de mama sin tener síntomas Sí   No   No Sé   
72. Un nódulo o bultito en las mamas es un signo definitivo de 
cancer 
Sí   No   No Sé   
73. Un síntoma del cáncer de mama es el cambio de textura de la 
piel en la mama 
Sí   No   No Sé   
74. Una mujer puede masajear o palpar sus mamas para sentir si 
tiene una masa dura 
Sí   No   No Sé   
75. Cuando más temprano se detecta el cáncer, más alta es la 
probabilidad de que la persona lo sobreviva 
Sí   No   No Sé   
76. Como parte del auto examen de mama, la mujer se mira las 
mamas en el espejo 
Sí   No   No Sé   
77. Como parte del auto examen de mama, la mujer aprieta su 
pezones 
Sí   No   No Sé   
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78. Una mujer necesita hacerse una mamografía únicamente cuando 
tiene problemas con sus mamas 
Sí   No   No Sé   
79. Una mamografía es un examen de rayos-X de la mama 
Sí   No   No Sé   
80. Una mamografía puede encontrar un pequeño nódulo o bultito 
en la mama antes de que el profesional de salud o yo la 
encontremos  
Sí   No   No Sé   
81. Una mamografía se hace para ver si hay un tumor creciendo en 
la mama 
Sí   No   No Sé   
82. Las mujeres jóvenes corren mayor riesgo de tener cáncer de 
mama que las mujeres de más edad 
Sí   No   No Sé   
 
Por favor responda a las siguientes afirmaciones con “sí”, “no”, o “no sé”. 
99. Es posible tener cáncer de cuello de útero sin tener síntomas   
Sí   No   No Sé   
100. Un síntoma del cáncer de cuello de útero es cuando una 
mujer sangra sin estar en la menstruación 
Sí   No   No Sé   
101. Una mujer debe hacerse el Papanicolaou únicamente  
después de haber tenido hijos 
Sí   No   No Sé   
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102. Una mujer debe hacerse el Papanicolaou únicamente cuando 
está teniendo una vida sexual active 
Sí   No   No Sé   
103. Una mujer debe hacerse el Papanicolaou únicamente cuando 
tiene un problema ginecológico 
Sí   No   No Sé   
104. Una mujer debe hacerse el Papanicolaou únicamente cuando 
está embarazada 
Sí   No   No Sé   
105. Una mujer que está en la menopausia debe hacerse el 
Papanicolaou 
Sí   No   No Sé   
106. Hacerse el Papanicolaou regularmente ayuda a prevenir que 
uno muera del cáncer de cuello de útero  
Sí   No   No Sé   
107. El Papanicolaou detecta el cáncer de cuello de útero 
Sí   No   No Sé   
108. El Papanicolaou se hace para ver si hay algún tumor   
creciendo en el cuello de útero 
Sí   No   No Sé   
 
 
